data_2lrq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.679 0.276 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.508 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.776 0.322 . . . . 1.0 110.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.544 0.212 . . . . 1.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.459 0.171 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.447 ' ND1' ' HH ' ' A' ' 48' ' ' TYR . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HH ' ' ND1' ' A' ' 23' ' ' HIS . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.705 0.288 . . . . 1.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 24' ' ' GLY . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.663 HD22 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.614 0.245 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.809 0.338 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.457 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.457 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.639 0.257 . . . . 1.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.561 ' HD1' ' NH2' ' A' ' 63' ' ' ARG . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' ALA . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.561 ' NH2' ' HD1' ' A' ' 23' ' ' HIS . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.43 0.157 . . . . 1.0 110.792 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 39' ' ' ALA . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.549 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.834 0.35 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.455 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -163.51 130.78 3.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -68.48 137.35 54.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.148 0.499 . . . . 1.0 110.13 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -64.35 -18.76 64.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.842 0.353 . . . . 1.0 110.832 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.44 ' HG1' ' H ' ' A' ' 6' ' ' GLY . 67.0 p -62.39 -45.01 95.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.814 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' H ' ' HG1' ' A' ' 5' ' ' THR . . . 178.8 -169.35 40.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 m -62.21 134.66 56.84 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.537 -0.39 . . . . 1.0 110.721 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -65.81 110.53 2.87 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.135 0.493 . . . . 1.0 110.944 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.19 147.57 53.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.634 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.508 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.87 -41.77 98.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.43 142.94 46.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.35 167.9 11.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.025 0.44 . . . . 1.0 110.325 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.784 -179.744 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -170.65 4.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.579 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.33 135.73 52.3 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.187 0.517 . . . . 1.0 110.321 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.6 m -68.12 142.09 55.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 1.0 110.408 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -65.39 135.58 55.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.588 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.53 -50.58 0.08 OUTLIER Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -64.32 -47.78 78.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.133 0.492 . . . . 1.0 110.257 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -69.49 135.19 49.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.422 0.629 . . . . 1.0 110.666 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 144.23 55.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.362 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -65.99 -30.0 70.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.74 -177.65 53.91 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.03 -3.69 30.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.633 -0.334 . . . . 1.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 117.97 -1.014 . . . . 1.0 111.157 179.782 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -67.51 125.71 27.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.11 -42.7 99.6 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.312 0.577 . . . . 1.0 110.56 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -161.62 168.57 23.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.995 0.426 . . . . 1.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -62.75 -38.57 91.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.79 0.25 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.87 144.61 57.15 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.475 -0.427 . . . . 1.0 110.558 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.3 -12.77 45.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.032 0.444 . . . . 1.0 110.917 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.32 105.5 0.93 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.749 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.22 -28.96 69.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.38 163.29 15.46 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -64.33 -39.44 93.89 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.615 -0.344 . . . . 1.0 110.362 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.135 -0.936 . . . . 1.0 110.026 179.801 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.467 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -77.26 87.01 3.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.359 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 52.05 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.969 0.414 . . . . 1.0 111.025 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 m -65.53 147.89 52.65 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.831 0.348 . . . . 1.0 110.353 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.1 p -66.39 140.9 58.1 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.35 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.66 -21.72 0.04 OUTLIER Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.25 -28.29 69.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.496 0.665 . . . . 1.0 109.893 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 10' ' ' ASN . 69.5 m-20 -63.12 113.44 3.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.863 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -71.88 11.6 0.51 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.996 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.428 ' H ' ' C ' ' A' ' 8' ' ' ASP . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.447 ' ND1' ' HH ' ' A' ' 48' ' ' TYR . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.569 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.447 ' HH ' ' ND1' ' A' ' 23' ' ' HIS . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.0 -31.04 68.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.67 143.64 7.45 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.3 141.77 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.66 -0.317 . . . . 1.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.297 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.89 160.72 19.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 1.0 110.227 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -153.14 156.05 37.9 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.764 0.792 . . . . 1.0 110.149 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.1 p -82.16 -115.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.318 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.8 p 48.53 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.552 0.215 . . . . 1.0 111.205 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.17 -48.31 1.4 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -64.9 131.22 46.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.123 0.461 . . . . 1.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 53.25 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.173 0.511 . . . . 1.0 111.349 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.52 114.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 24' ' ' GLY . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.42 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.483 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.663 ' N ' HD22 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.663 HD22 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t -63.98 -22.64 67.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.16 -178.51 51.33 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 167.68 3.94 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.652 -0.322 . . . . 1.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.16 -0.924 . . . . 1.0 109.101 179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -169.82 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.705 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -159.81 163.81 34.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.594 0.712 . . . . 1.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -161.23 162.82 31.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.353 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.6 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.31 62.26 5.56 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.97 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.91 149.45 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.348 0.594 . . . . 1.0 111.164 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.71 102.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.302 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.496 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.97 -38.0 86.87 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' ARG . . . -62.88 -40.31 99.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 56.89 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.699 0.4 . . . . 1.0 111.206 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' GLY . 58.1 ttp180 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.497 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' H2 ' ' H ' ' A' ' 2' ' ' ASN . 63.0 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.408 ' H ' ' H2 ' ' A' ' 1' ' ' MET . 15.1 m120 -65.76 164.75 14.02 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.221 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.72 -44.81 96.2 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.979 0.419 . . . . 1.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m 53.18 -167.78 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.24 -0.287 . . . . 1.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -61.84 -45.43 93.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.928 0.394 . . . . 1.0 110.808 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.53 -167.62 34.83 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.497 ' HG1' ' N ' ' A' ' 8' ' ' ASP . 3.4 t -63.66 151.55 41.49 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.5 -0.412 . . . . 1.0 110.67 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.497 ' N ' ' HG1' ' A' ' 7' ' ' THR . 21.8 p-10 -166.44 80.2 0.25 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.487 0.66 . . . . 1.0 110.775 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.16 147.73 50.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.772 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.457 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -66.83 -23.32 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.52 -40.67 99.02 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.464 -0.655 . . . . 1.0 111.464 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.05 140.52 58.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.837 0.351 . . . . 1.0 110.655 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.395 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -63.99 -35.54 81.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.003 0.43 . . . . 1.0 110.849 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.11 141.44 58.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.329 0.585 . . . . 1.0 110.343 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -162.97 -69.48 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.5 p -67.3 138.35 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 1.0 110.43 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.17 -91.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m 54.73 77.95 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.057 0.456 . . . . 1.0 110.259 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -166.89 167.95 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.933 0.873 . . . . 1.0 110.809 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.48 83.02 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.65 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.561 ' HD1' ' NH2' ' A' ' 63' ' ' ARG . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 39' ' ' ALA . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.561 ' NH2' ' HD1' ' A' ' 23' ' ' HIS . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.71 -35.8 81.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.02 164.1 36.65 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.94 134.77 57.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.788 0.327 . . . . 1.0 111.003 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 117.91 -1.043 . . . . 1.0 111.318 179.714 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 tpp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.37 117.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.772 0.32 . . . . 1.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -61.03 -47.45 86.36 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.294 0.568 . . . . 1.0 110.566 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.7 p -167.6 160.92 13.31 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.011 0.434 . . . . 1.0 110.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.6 m -65.31 132.56 49.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.84 177.58 46.74 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.35 158.99 30.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.455 0.645 . . . . 1.0 110.427 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -149.29 11.73 0.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -69.5 2.1 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.696 -0.229 . . . . 1.0 110.792 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 39' ' ' ALA . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.433 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.549 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.47 -42.08 98.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.21 -173.7 44.68 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -169.08 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.669 -0.313 . . . . 1.0 110.807 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 78.1 mtt85 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 118.083 -0.961 . . . . 1.0 111.191 179.691 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -64.19 152.83 39.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -167.95 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 98.4 p -60.94 -32.9 72.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.789 0.328 . . . . 1.0 110.776 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.1 p -62.06 -47.07 86.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.726 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.07 83.17 0.05 OUTLIER Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -155.76 142.31 18.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.26 0.552 . . . . 1.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -68.45 -68.13 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.617 0.722 . . . . 1.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 139.77 58.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.82 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.459 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.455 ' CG2' ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.455 ' H ' ' CG2' ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.86 -43.57 94.6 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.35 -152.3 44.63 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 53.93 97.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.702 -0.293 . . . . 1.0 111.065 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.209 -0.901 . . . . 1.0 111.403 -179.863 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.679 0.276 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.638 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.776 0.322 . . . . 1.0 110.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.45 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 66' ' ' LYS . 86.8 m-20 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.544 0.212 . . . . 1.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' VAL . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.459 0.171 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 42' ' ' VAL . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.891 HG22 ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.891 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.705 0.288 . . . . 1.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 12' ' ' LEU . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 22' ' ' PHE . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG21 ' A' ' 42' ' ' VAL . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' H ' HG22 ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.71 ' N ' HD21 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.614 0.245 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.625 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.809 0.338 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.639 0.257 . . . . 1.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.43 0.157 . . . . 1.0 110.792 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.661 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG22 ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.878 ' H ' HG22 ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.834 0.35 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 75' ' ' ARG . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 29' ' ' GLU . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 30.4 t30 -163.51 130.78 3.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -68.48 137.35 54.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.148 0.499 . . . . 1.0 110.13 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -64.35 -18.76 64.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.842 0.353 . . . . 1.0 110.832 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 p -62.39 -45.01 95.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.814 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.8 -169.35 40.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 m -62.21 134.66 56.84 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.537 -0.39 . . . . 1.0 110.721 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -65.81 110.53 2.87 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.135 0.493 . . . . 1.0 110.944 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.19 147.57 53.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.634 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 18.7 p-80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.87 -41.77 98.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.43 142.94 46.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.35 167.9 11.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.025 0.44 . . . . 1.0 110.325 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.784 -179.744 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -170.65 4.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.579 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.33 135.73 52.3 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.187 0.517 . . . . 1.0 110.321 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.6 m -68.12 142.09 55.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 1.0 110.408 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -65.39 135.58 55.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.588 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.53 -50.58 0.08 OUTLIER Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -64.32 -47.78 78.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.133 0.492 . . . . 1.0 110.257 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -69.49 135.19 49.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.422 0.629 . . . . 1.0 110.666 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 144.23 55.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.362 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' O ' ' ND2' ' A' ' 71' ' ' ASN . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' ' O ' ' A' ' 66' ' ' LYS . 86.8 m-20 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -65.99 -30.0 70.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.74 -177.65 53.91 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.03 -3.69 30.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.633 -0.334 . . . . 1.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 117.97 -1.014 . . . . 1.0 111.157 179.782 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -67.51 125.71 27.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.11 -42.7 99.6 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.312 0.577 . . . . 1.0 110.56 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -161.62 168.57 23.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.995 0.426 . . . . 1.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -62.75 -38.57 91.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.79 0.25 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.87 144.61 57.15 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.475 -0.427 . . . . 1.0 110.558 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.3 -12.77 45.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.032 0.444 . . . . 1.0 110.917 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.32 105.5 0.93 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.749 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' VAL . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.22 -28.96 69.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.38 163.29 15.46 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -64.33 -39.44 93.89 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.615 -0.344 . . . . 1.0 110.362 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.135 -0.936 . . . . 1.0 110.026 179.801 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -77.26 87.01 3.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.359 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 52.05 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.969 0.414 . . . . 1.0 111.025 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 m -65.53 147.89 52.65 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.831 0.348 . . . . 1.0 110.353 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.1 p -66.39 140.9 58.1 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.35 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.66 -21.72 0.04 OUTLIER Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.25 -28.29 69.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.496 0.665 . . . . 1.0 109.893 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 10' ' ' ASN . 69.5 m-20 -63.12 113.44 3.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.863 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -71.88 11.6 0.51 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.996 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 8' ' ' ASP . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 42' ' ' VAL . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.891 HG22 ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.891 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 33.8 p-80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.0 -31.04 68.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.67 143.64 7.45 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.3 141.77 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.66 -0.317 . . . . 1.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.297 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.89 160.72 19.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 1.0 110.227 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -153.14 156.05 37.9 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.764 0.792 . . . . 1.0 110.149 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.1 p -82.16 -115.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.318 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.8 p 48.53 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.552 0.215 . . . . 1.0 111.205 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.17 -48.31 1.4 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -64.9 131.22 46.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.123 0.461 . . . . 1.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 53.25 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.173 0.511 . . . . 1.0 111.349 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.52 114.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 12' ' ' LEU . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 22' ' ' PHE . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG21 ' A' ' 42' ' ' VAL . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' H ' HG22 ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.71 ' N ' HD21 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t -63.98 -22.64 67.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.16 -178.51 51.33 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 167.68 3.94 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.652 -0.322 . . . . 1.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.16 -0.924 . . . . 1.0 109.101 179.853 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -169.82 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.705 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -159.81 163.81 34.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.594 0.712 . . . . 1.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -161.23 162.82 31.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.353 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.6 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.31 62.26 5.56 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.97 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.91 149.45 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.348 0.594 . . . . 1.0 111.164 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.71 102.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.302 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.625 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.97 -38.0 86.87 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' ARG . . . -62.88 -40.31 99.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 56.89 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.699 0.4 . . . . 1.0 111.206 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' GLY . 58.1 ttp180 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.497 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -65.76 164.75 14.02 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.72 -44.81 96.2 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.979 0.419 . . . . 1.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m 53.18 -167.78 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.24 -0.287 . . . . 1.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -61.84 -45.43 93.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.928 0.394 . . . . 1.0 110.808 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.53 -167.62 34.83 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.66 151.55 41.49 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.5 -0.412 . . . . 1.0 110.67 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -166.44 80.2 0.25 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.487 0.66 . . . . 1.0 110.775 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.16 147.73 50.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.772 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -66.83 -23.32 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.52 -40.67 99.02 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.464 -0.655 . . . . 1.0 111.464 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.05 140.52 58.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.837 0.351 . . . . 1.0 110.655 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.395 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -63.99 -35.54 81.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.003 0.43 . . . . 1.0 110.849 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.11 141.44 58.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.329 0.585 . . . . 1.0 110.343 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -162.97 -69.48 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.5 p -67.3 138.35 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 1.0 110.43 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.17 -91.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m 54.73 77.95 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.057 0.456 . . . . 1.0 110.259 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -166.89 167.95 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.933 0.873 . . . . 1.0 110.809 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.48 83.02 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.65 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.71 -35.8 81.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.02 164.1 36.65 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.94 134.77 57.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.788 0.327 . . . . 1.0 111.003 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 117.91 -1.043 . . . . 1.0 111.318 179.714 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 tpp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.37 117.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.772 0.32 . . . . 1.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -61.03 -47.45 86.36 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.294 0.568 . . . . 1.0 110.566 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.7 p -167.6 160.92 13.31 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.011 0.434 . . . . 1.0 110.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.6 m -65.31 132.56 49.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.84 177.58 46.74 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.35 158.99 30.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.455 0.645 . . . . 1.0 110.427 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -149.29 11.73 0.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -69.5 2.1 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.696 -0.229 . . . . 1.0 110.792 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.661 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG22 ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.878 ' H ' HG22 ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.47 -42.08 98.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.21 -173.7 44.68 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 85' ' ' ARG . 11.0 pt-20 -169.08 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.669 -0.313 . . . . 1.0 110.807 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' A' ' 84' ' ' GLU . 78.1 mtt85 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 118.083 -0.961 . . . . 1.0 111.191 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -64.19 152.83 39.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' H ' ' H ' ' A' ' 4' ' ' SER . 68.6 t80 -167.95 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 3' ' ' TYR . 98.4 p -60.94 -32.9 72.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.789 0.328 . . . . 1.0 110.776 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.1 p -62.06 -47.07 86.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.726 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.07 83.17 0.05 OUTLIER Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -155.76 142.31 18.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.26 0.552 . . . . 1.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -68.45 -68.13 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.617 0.722 . . . . 1.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 139.77 58.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.82 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 75' ' ' ARG . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 29' ' ' GLU . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.86 -43.57 94.6 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.35 -152.3 44.63 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 53.93 97.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.702 -0.293 . . . . 1.0 111.065 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.209 -0.901 . . . . 1.0 111.403 -179.863 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.361 0 CA-C-O 120.679 0.276 . . . . 1.0 110.634 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.638 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.336 0 CA-C-O 120.776 0.322 . . . . 1.0 110.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.593 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m . . . . . 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.477 0 CA-C-O 120.544 0.212 . . . . 1.0 110.749 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' VAL . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.469 0.494 0 CA-C-O 120.459 0.171 . . . . 1.0 110.996 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 42' ' ' VAL . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.891 HG22 ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.891 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t . . . . . 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.757 0 CA-C-O 120.705 0.288 . . . . 1.0 111.191 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 12' ' ' LEU . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 22' ' ' PHE . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG21 ' A' ' 42' ' ' VAL . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' H ' HG22 ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.71 ' N ' HD21 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.67 0 CA-C-O 120.614 0.245 . . . . 1.0 111.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.625 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t . . . . . 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 120.809 0.338 . . . . 1.0 110.772 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.392 0 CA-C-O 120.639 0.257 . . . . 1.0 110.65 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m . . . . . 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . . . . . . 0 N--CA 1.465 0.293 0 CA-C-O 120.43 0.157 . . . . 1.0 110.792 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.661 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG22 ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.878 ' H ' HG22 ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.53 0 CA-C-O 120.834 0.35 . . . . 1.0 110.82 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 75' ' ' ARG . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 29' ' ' GLU . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t . . . . . 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.2 ttm . . . . . 0 N--CA 1.489 1.495 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -163.51 130.78 3.44 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.084 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -68.48 137.35 54.36 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.148 0.499 . . . . 1.0 110.13 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 39.0 t -64.35 -18.76 64.95 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.842 0.353 . . . . 1.0 110.832 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 67.0 p -62.39 -45.01 95.08 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.425 . . . . 1.0 110.814 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.8 -169.35 40.78 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 111.27 -0.732 . . . . 1.0 111.27 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.0 m -62.21 134.66 56.84 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 122.537 -0.39 . . . . 1.0 110.721 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.5 p-10 -65.81 110.53 2.87 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 121.135 0.493 . . . . 1.0 110.944 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.19 147.57 53.13 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.338 -0.392 . . . . 1.0 110.634 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -63.79 -40.87 97.7 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.104 0.478 . . . . 1.0 110.462 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 74.7 p -65.19 149.61 49.62 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 121.399 0.618 . . . . 1.0 110.035 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 45.7 mt -79.65 -6.02 56.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.119 -0.491 . . . . 1.0 110.386 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -116.69 147.06 42.32 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.049 0.54 . . . . 1.0 111.136 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.19 158.71 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-O 121.287 0.565 . . . . 1.0 110.702 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -64.09 141.16 58.87 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-O 121.882 0.848 . . . . 1.0 111.558 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.61 -8.2 78.31 Favored Glycine 0 N--CA 1.472 1.056 0 N-CA-C 111.09 -0.804 . . . . 1.0 111.09 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -73.17 146.19 45.79 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.354 0.597 . . . . 1.0 110.903 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 -97.86 128.34 44.4 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 109.049 -0.723 . . . . 1.0 109.049 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.1 m -136.45 172.27 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 CA-C-O 121.944 0.878 . . . . 1.0 110.409 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.9 mt -107.18 141.32 38.66 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 115.467 -0.788 . . . . 1.0 110.494 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.2 t -121.44 112.76 18.93 Favored 'General case' 0 N--CA 1.483 1.217 0 CA-C-N 115.929 -0.578 . . . . 1.0 110.386 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -103.22 153.76 20.03 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.653 0.739 . . . . 1.0 110.017 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 77.9 t60 -165.33 26.65 0.05 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.893 -0.505 . . . . 1.0 110.046 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 177.32 -154.55 15.89 Favored Glycine 0 CA--C 1.548 2.124 0 CA-C-O 118.966 -0.908 . . . . 1.0 111.687 -179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.32 4.28 6.03 Favored 'Trans proline' 0 N--CA 1.514 2.696 0 CA-C-N 119.364 1.582 . . . . 1.0 112.69 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 16.7 mt -135.17 152.49 51.65 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 122.334 1.064 . . . . 1.0 110.908 179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 80.9 mt -102.35 131.98 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 114.713 -1.131 . . . . 1.0 109.322 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -114.91 154.34 28.87 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.556 0.693 . . . . 1.0 110.753 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -84.29 144.78 28.66 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.531 0.681 . . . . 1.0 110.938 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -151.84 173.19 15.08 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.862 -0.608 . . . . 1.0 109.881 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -139.9 142.08 36.5 Favored 'General case' 0 N--CA 1.486 1.36 0 CA-C-O 121.697 0.76 . . . . 1.0 111.182 -179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 22.1 t -87.88 110.89 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 109.24 -0.652 . . . . 1.0 109.24 179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 7.4 tp -76.07 -37.02 58.73 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 122.096 -0.377 . . . . 1.0 110.218 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -165.43 164.04 19.63 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.012 0.434 . . . . 1.0 109.88 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.8 t -141.55 152.87 44.47 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.166 0.508 . . . . 1.0 111.103 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.7 tttt -111.1 86.21 5.97 Favored Pre-proline 0 N--CA 1.497 1.922 0 CA-C-O 118.126 -0.94 . . . . 1.0 110.229 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -82.09 8.33 4.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.21 1.94 . . . . 1.0 112.349 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -71.55 8.33 1.14 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.352 0.261 . . . . 1.0 111.095 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.7 157.2 21.42 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.642 0.734 . . . . 1.0 111.261 -179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 69.8 p -143.38 113.57 5.64 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 118.239 -0.886 . . . . 1.0 111.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.36 -178.98 18.85 Favored 'Cis proline' 0 N--CA 1.514 2.692 0 CA-C-N 120.635 1.262 . . . . 1.0 110.641 0.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.638 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -167.39 176.73 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 115.88 -0.6 . . . . 1.0 111.004 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.638 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.9 pp20? -96.62 162.59 13.38 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 123.096 1.427 . . . . 1.0 110.101 179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -134.52 145.84 49.14 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 114.888 -1.051 . . . . 1.0 110.767 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -95.89 118.54 32.72 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 114.901 -1.045 . . . . 1.0 110.244 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 6.0 mt -141.18 149.36 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-O 121.836 0.826 . . . . 1.0 110.103 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -142.74 145.97 33.85 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.534 0.683 . . . . 1.0 109.75 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -71.02 131.83 44.25 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.8 0.81 . . . . 1.0 110.146 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.09 141.7 56.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.988 -0.551 . . . . 1.0 111.042 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 81.63 15.64 75.3 Favored Glycine 0 N--CA 1.472 1.088 0 N-CA-C 111.394 -0.683 . . . . 1.0 111.394 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -139.09 166.48 24.4 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-O 122.114 0.959 . . . . 1.0 110.715 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.0 p -60.89 132.47 53.98 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 115.48 -0.782 . . . . 1.0 110.842 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 61.7 pttt -82.49 -8.65 59.61 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.089 0.555 . . . . 1.0 111.113 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -68.79 -9.55 51.63 Favored 'General case' 0 N--CA 1.467 0.42 0 O-C-N 121.946 -0.471 . . . . 1.0 110.733 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 14.2 t-105 -68.04 -29.41 68.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.245 0.545 . . . . 1.0 109.769 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 44.63 73.96 0.14 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.675 0.621 . . . . 1.0 112.675 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.5 tp10 -87.8 94.76 9.85 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 121.5 -0.75 . . . . 1.0 110.522 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -83.42 128.44 34.51 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.746 -0.835 . . . . 1.0 108.746 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.3 m -142.96 149.21 48.53 Favored Pre-proline 0 N--CA 1.499 1.988 0 N-CA-C 112.754 0.65 . . . . 1.0 112.754 -178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -76.01 156.78 38.62 Favored 'Trans proline' 0 N--CA 1.516 2.832 0 C-N-CA 121.689 1.593 . . . . 1.0 111.88 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -50.32 -21.22 1.31 Allowed 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.326 0.584 . . . . 1.0 111.709 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -63.92 -40.91 97.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.116 -0.365 . . . . 1.0 111.658 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.2 tpp85 -86.84 2.89 47.49 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 122.123 -0.361 . . . . 1.0 111.086 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.2 t -99.52 131.81 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 CA-C-O 122.03 0.919 . . . . 1.0 110.107 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.3 tp -119.79 134.62 55.17 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.63 0.728 . . . . 1.0 110.318 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -66.1 146.18 54.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.062 -0.517 . . . . 1.0 110.63 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -84.17 119.38 24.94 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.323 -0.621 . . . . 1.0 109.323 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -154.31 146.81 24.04 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 116.334 -0.394 . . . . 1.0 110.434 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -48.09 -27.84 2.55 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.732 -0.667 . . . . 1.0 111.762 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -71.93 -45.25 61.82 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 110.197 -0.298 . . . . 1.0 110.197 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.66 -36.15 82.84 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.741 -0.837 . . . . 1.0 108.741 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.0 t -65.73 -44.0 93.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 107.899 -1.149 . . . . 1.0 107.899 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -55.43 -42.17 73.81 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 121.332 0.587 . . . . 1.0 109.663 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 70.3 mtp85 -63.87 -40.39 96.44 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 116.252 -0.431 . . . . 1.0 110.123 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -68.0 -37.36 81.36 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 122.677 1.227 . . . . 1.0 108.336 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.4 tt0 -66.22 -40.04 90.01 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 114.768 -1.106 . . . . 1.0 108.163 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.11 -51.43 64.0 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 47.7 mt -60.16 -39.19 85.52 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 109.615 -0.513 . . . . 1.0 109.615 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.03 -45.68 92.51 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 110.145 -0.317 . . . . 1.0 110.145 179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -66.51 -41.31 89.04 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.312 -0.625 . . . . 1.0 109.312 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -63.68 -36.67 84.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 1.0 109.949 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.87 -41.77 98.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.024 0.44 . . . . 1.0 110.641 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.43 142.94 46.44 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 110.742 -0.943 . . . . 1.0 110.742 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -168.35 167.9 11.68 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.025 0.44 . . . . 1.0 110.325 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.784 -179.744 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtp . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 108.895 -0.78 . . . . 1.0 108.895 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -170.65 4.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 116.149 -0.478 . . . . 1.0 110.579 -179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -68.33 135.73 52.3 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.187 0.517 . . . . 1.0 110.321 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.6 m -68.12 142.09 55.88 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 120.822 0.344 . . . . 1.0 110.408 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.8 m -65.39 135.58 55.44 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.316 -0.402 . . . . 1.0 110.588 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -179.53 -50.58 0.08 OUTLIER Glycine 0 N--CA 1.468 0.822 0 N-CA-C 111.2 -0.76 . . . . 1.0 111.2 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -64.32 -47.78 78.12 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.133 0.492 . . . . 1.0 110.257 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -69.49 135.19 49.81 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 121.422 0.629 . . . . 1.0 110.666 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.04 144.23 55.19 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.056 -0.52 . . . . 1.0 110.362 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -64.68 -40.64 95.74 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.24 0.543 . . . . 1.0 110.223 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 75.0 p -70.49 155.13 41.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.572 0.701 . . . . 1.0 109.96 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.66 -4.12 59.07 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-N 115.939 -0.573 . . . . 1.0 110.074 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -117.31 141.38 48.38 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.265 0.555 . . . . 1.0 110.82 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.1 m -131.14 155.32 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 CA-C-O 121.552 0.691 . . . . 1.0 110.506 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -62.45 144.09 56.33 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.103 0.954 . . . . 1.0 111.454 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.94 -10.3 73.3 Favored Glycine 0 N--CA 1.47 0.932 0 N-CA-C 110.859 -0.896 . . . . 1.0 110.859 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.1 tt0 -78.32 140.43 38.8 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.31 0.576 . . . . 1.0 110.874 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.9 tpp180 -85.39 130.73 34.53 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.7 m -138.35 170.25 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 CA-C-O 121.923 0.868 . . . . 1.0 110.425 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 67.9 mt -113.91 142.0 46.67 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 121.976 0.893 . . . . 1.0 110.404 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.7 m -125.08 114.73 19.45 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 115.734 -0.666 . . . . 1.0 110.301 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -92.64 153.12 19.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-O 121.581 0.705 . . . . 1.0 109.767 179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 75.4 t60 -157.32 10.08 0.2 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.821 -0.549 . . . . 1.0 110.081 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.37 -168.77 40.14 Favored Glycine 0 CA--C 1.539 1.581 0 N-CA-C 111.445 -0.662 . . . . 1.0 111.445 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.57 1.01 0.11 Allowed 'Trans proline' 0 N--CA 1.513 2.666 0 C-N-CA 122.172 1.914 . . . . 1.0 113.313 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 24' ' ' GLY . 16.2 mt -134.77 151.09 50.69 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-O 122.523 1.154 . . . . 1.0 111.228 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 79.3 mt -99.14 141.16 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 114.444 -1.253 . . . . 1.0 109.07 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -120.18 151.18 39.49 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-N 115.49 -0.777 . . . . 1.0 110.734 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -82.11 141.36 33.18 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.623 0.725 . . . . 1.0 110.646 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 173.84 14.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.613 -0.721 . . . . 1.0 109.822 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.9 ttpm? -147.53 143.86 28.11 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-O 121.884 0.85 . . . . 1.0 111.107 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -85.74 114.93 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.943 -0.571 . . . . 1.0 110.008 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.8 -34.7 16.98 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 122.123 -0.361 . . . . 1.0 110.39 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.1 ttmt -153.98 155.68 36.02 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 121.419 0.628 . . . . 1.0 109.88 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.3 t -143.34 146.57 33.65 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.674 -0.693 . . . . 1.0 110.783 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.4 tttt -112.48 82.15 4.55 Favored Pre-proline 0 N--CA 1.49 1.535 0 CA-C-O 118.345 -0.836 . . . . 1.0 109.929 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -80.21 11.78 2.72 Favored 'Trans proline' 0 N--CA 1.516 2.826 0 C-N-CA 122.098 1.865 . . . . 1.0 112.478 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -69.41 1.22 4.11 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.778 0.323 . . . . 1.0 111.372 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.2 160.07 23.64 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.382 0.611 . . . . 1.0 111.203 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.8 p -141.91 117.6 7.02 Favored Pre-proline 0 CA--C 1.565 1.539 0 CA-C-O 117.892 -1.052 . . . . 1.0 111.337 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.15 177.21 33.35 Favored 'Cis proline' 0 N--CA 1.516 2.819 0 CA-C-N 120.97 1.382 . . . . 1.0 110.679 -0.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.593 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.9 p -166.81 175.92 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 CA-C-N 115.838 -0.619 . . . . 1.0 110.858 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.593 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.0 pt-20 -94.44 161.2 14.32 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 123.066 1.412 . . . . 1.0 110.197 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -135.66 144.31 45.95 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.957 -1.02 . . . . 1.0 110.859 -179.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -89.9 114.29 26.05 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 114.911 -1.04 . . . . 1.0 109.945 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.7 mt -139.88 148.65 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.31 0.576 . . . . 1.0 110.234 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -143.52 148.02 35.37 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.685 0.755 . . . . 1.0 109.718 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -65.26 136.29 56.41 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.413 0.625 . . . . 1.0 110.248 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -63.44 141.39 58.78 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.16 0.505 . . . . 1.0 111.15 -179.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.93 25.01 56.95 Favored Glycine 0 N--CA 1.474 1.188 0 N-CA-C 111.296 -0.722 . . . . 1.0 111.296 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -143.53 156.9 44.74 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.061 0.934 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 92.1 p -66.37 157.23 32.36 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.529 -0.759 . . . . 1.0 110.629 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -83.35 -4.41 58.43 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.681 0.792 . . . . 1.0 111.315 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -62.42 -23.01 66.62 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.979 0.418 . . . . 1.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 42.6 m95 -67.28 -33.71 75.88 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 37.94 75.1 0.07 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.605 0.762 . . . . 1.0 112.997 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -90.76 99.94 12.88 Favored 'General case' 0 N--CA 1.474 0.749 0 O-C-N 121.467 -0.771 . . . . 1.0 110.45 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -83.02 129.62 35.05 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.723 -0.843 . . . . 1.0 108.723 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.99 157.32 64.31 Favored Pre-proline 0 N--CA 1.501 2.081 0 N-CA-C 112.865 0.691 . . . . 1.0 112.865 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.08 158.36 30.42 Favored 'Trans proline' 0 N--CA 1.511 2.518 0 C-N-CA 121.699 1.599 . . . . 1.0 111.089 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -54.04 -16.22 1.84 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.364 0.602 . . . . 1.0 111.454 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -64.32 -42.74 96.17 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 122.104 -0.373 . . . . 1.0 111.915 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -82.11 -0.36 44.33 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.102 -0.373 . . . . 1.0 110.988 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.23 125.73 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-O 121.876 0.846 . . . . 1.0 110.405 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.5 tp -119.46 134.73 55.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.565 0.698 . . . . 1.0 110.289 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -60.52 142.12 55.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.126 -0.488 . . . . 1.0 110.942 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -85.09 117.21 23.91 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.7 0.762 . . . . 1.0 109.463 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -153.06 143.43 22.52 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 115.951 -0.568 . . . . 1.0 110.262 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -43.62 -27.68 0.32 Allowed 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.727 -0.67 . . . . 1.0 111.518 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -72.74 -46.65 52.36 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 122.716 0.406 . . . . 1.0 110.484 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.5 m120 -65.98 -34.08 77.28 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.948 -0.76 . . . . 1.0 108.948 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.5 t -67.27 -43.19 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 N-CA-C 107.706 -1.22 . . . . 1.0 107.706 178.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -57.34 -40.21 77.53 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.021 -0.536 . . . . 1.0 109.589 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -62.25 -37.51 85.69 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 109.384 -0.599 . . . . 1.0 109.384 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -66.93 -38.79 86.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -65.49 -41.81 92.87 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.63 -0.878 . . . . 1.0 108.63 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -60.92 -50.52 73.09 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.831 -0.803 . . . . 1.0 108.831 178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 51.2 mt -61.34 -39.07 89.21 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 109.689 -0.486 . . . . 1.0 109.689 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -61.21 -43.19 99.28 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 110.073 -0.343 . . . . 1.0 110.073 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -68.89 -40.86 78.97 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 109.213 -0.662 . . . . 1.0 109.213 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 11.7 tp-100 -56.94 -42.71 80.55 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 120.98 0.419 . . . . 1.0 110.158 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 72.6 m -65.99 -30.0 70.48 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.571 0.348 . . . . 1.0 110.257 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.74 -177.65 53.91 Favored Glycine 0 N--CA 1.468 0.812 0 N-CA-C 110.981 -0.848 . . . . 1.0 110.981 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -74.03 -3.69 30.83 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.633 -0.334 . . . . 1.0 110.602 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 . . . . . 0 N--CA 1.47 0.537 0 CA-C-O 117.97 -1.014 . . . . 1.0 111.157 179.782 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.6 mtt . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 108.552 -0.907 . . . . 1.0 108.552 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -67.51 125.71 27.02 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 116.15 -0.477 . . . . 1.0 110.414 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -63.11 -42.7 99.6 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.312 0.577 . . . . 1.0 110.56 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.1 m -161.62 168.57 23.2 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.995 0.426 . . . . 1.0 110.381 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 69.1 p -62.75 -38.57 91.09 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.186 -0.461 . . . . 1.0 110.738 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.61 90.79 0.25 Allowed Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.113 -0.795 . . . . 1.0 111.113 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.87 144.61 57.15 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.475 -0.427 . . . . 1.0 110.558 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -64.3 -12.77 45.04 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.032 0.444 . . . . 1.0 110.917 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.32 105.5 0.93 Allowed 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 116.44 -0.345 . . . . 1.0 110.749 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -63.36 -37.4 87.12 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.156 0.503 . . . . 1.0 110.194 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 77.8 p -64.1 156.39 28.49 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.479 0.657 . . . . 1.0 110.212 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 10.0 mp -84.87 0.01 52.46 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 116.055 -0.521 . . . . 1.0 109.979 -179.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -117.32 140.42 49.59 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 121.646 0.736 . . . . 1.0 110.819 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.62 160.76 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 CA-C-N 115.568 -0.742 . . . . 1.0 110.71 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 57.3 t0 -64.09 144.1 57.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.073 0.94 . . . . 1.0 111.252 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.401 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 88.06 -14.36 59.14 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 111.021 -0.832 . . . . 1.0 111.021 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.41 139.34 49.69 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.286 0.565 . . . . 1.0 110.723 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -92.72 127.29 38.16 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.047 -0.723 . . . . 1.0 109.047 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.2 m -135.51 167.38 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 CA-C-O 122.023 0.916 . . . . 1.0 110.321 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 68.6 mt -104.51 144.93 31.01 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.353 -0.839 . . . . 1.0 110.239 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.9 t -124.77 114.25 19.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 115.952 -0.567 . . . . 1.0 110.511 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -98.07 156.5 16.62 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-O 121.534 0.683 . . . . 1.0 109.889 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -164.95 16.0 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 121.906 -0.496 . . . . 1.0 110.34 -179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 179.7 -167.94 38.07 Favored Glycine 0 CA--C 1.538 1.523 0 N-CA-C 111.387 -0.685 . . . . 1.0 111.387 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.67 11.51 0.06 OUTLIER 'Trans proline' 0 N--CA 1.513 2.669 0 C-N-CA 121.771 1.647 . . . . 1.0 113.174 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' H ' ' C ' ' A' ' 24' ' ' GLY . 39.2 tp -147.84 141.03 25.08 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.985 0.898 . . . . 1.0 111.122 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 75.2 mt -86.97 150.63 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 CA-C-N 115.04 -0.982 . . . . 1.0 109.716 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.1 159.31 38.0 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.798 0.809 . . . . 1.0 110.688 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -85.53 140.21 30.83 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.505 0.669 . . . . 1.0 111.187 -179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.37 171.75 14.97 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.474 0.654 . . . . 1.0 109.7 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -141.56 147.51 37.82 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.73 0.776 . . . . 1.0 110.855 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.7 t -91.06 110.02 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 109.446 -0.576 . . . . 1.0 109.446 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.6 tp -84.82 -34.71 22.65 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 122.096 -0.378 . . . . 1.0 110.185 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -160.21 153.74 22.38 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.608 0.718 . . . . 1.0 110.136 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 59.8 p -134.86 144.56 47.63 Favored 'General case' 0 N--CA 1.481 1.085 0 CA-C-N 115.509 -0.768 . . . . 1.0 111.006 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.482 ' O ' HG21 ' A' ' 42' ' ' VAL . 63.7 tttm -113.89 81.9 6.32 Favored Pre-proline 0 N--CA 1.486 1.344 0 CA-C-O 118.568 -0.73 . . . . 1.0 109.819 178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -82.63 9.65 3.95 Favored 'Trans proline' 0 N--CA 1.51 2.457 0 C-N-CA 122.233 1.955 . . . . 1.0 112.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -68.39 -4.51 14.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.675 0.274 . . . . 1.0 110.819 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -150.38 159.47 44.44 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-O 121.997 0.903 . . . . 1.0 111.565 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 59.2 p -144.24 113.58 5.25 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 118.199 -0.905 . . . . 1.0 111.289 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.26 178.87 20.39 Favored 'Cis proline' 0 N--CA 1.513 2.639 0 CA-C-N 120.643 1.265 . . . . 1.0 110.577 -0.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.615 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.22 175.12 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 115.966 -0.561 . . . . 1.0 110.741 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.615 ' H ' HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -97.26 162.13 13.48 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-O 123.256 1.503 . . . . 1.0 109.313 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -135.21 155.31 50.89 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 122.677 1.227 . . . . 1.0 110.554 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -96.03 99.28 11.06 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.379 -1.282 . . . . 1.0 110.168 -179.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.2 mm -110.66 146.68 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 114.686 -1.143 . . . . 1.0 110.166 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 40.3 m-70 -123.09 129.97 52.16 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.055 0.931 . . . . 1.0 109.587 179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -84.03 122.26 28.54 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.59 0.709 . . . . 1.0 109.789 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.72 147.68 52.61 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.218 0.533 . . . . 1.0 110.826 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.07 5.43 76.83 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 111.539 -0.625 . . . . 1.0 111.539 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.2 m95 -143.2 161.73 37.48 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 122.09 0.948 . . . . 1.0 110.869 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.3 m -64.99 166.89 8.57 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.63 -0.714 . . . . 1.0 110.474 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -82.55 -10.37 59.01 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.207 -0.451 . . . . 1.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -66.21 -17.04 64.49 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 122.046 -0.409 . . . . 1.0 110.727 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.9 m95 -67.23 -33.33 75.13 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 109.625 -0.509 . . . . 1.0 109.625 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 41.68 75.46 0.09 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.505 0.722 . . . . 1.0 112.929 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -78.2 92.59 4.47 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.459 -0.775 . . . . 1.0 110.188 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -89.6 119.63 30.18 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.286 -1.005 . . . . 1.0 108.286 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 m -147.27 152.65 43.25 Favored Pre-proline 0 N--CA 1.497 1.882 0 N-CA-C 112.574 0.583 . . . . 1.0 112.574 -178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -70.46 163.44 38.82 Favored 'Trans proline' 0 N--CA 1.517 2.857 0 C-N-CA 121.602 1.535 . . . . 1.0 112.135 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -51.75 -24.51 5.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.906 -0.588 . . . . 1.0 111.253 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -58.39 -39.78 80.58 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.519 -0.31 . . . . 1.0 111.771 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 14.1 tpp180 -86.23 -2.65 58.57 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 122.031 -0.418 . . . . 1.0 110.813 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 40.6 t -96.38 126.47 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 CA-C-O 121.925 0.869 . . . . 1.0 110.062 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 52.0 tp -112.79 134.15 54.44 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 121.644 0.735 . . . . 1.0 109.904 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -66.31 145.01 56.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.987 -0.551 . . . . 1.0 110.63 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -84.49 120.5 26.39 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.355 -0.609 . . . . 1.0 109.355 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -154.95 150.71 27.68 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 116.317 -0.401 . . . . 1.0 110.565 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -49.74 -31.72 12.05 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.772 -0.649 . . . . 1.0 111.69 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -72.49 -42.17 65.18 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 110.017 -0.364 . . . . 1.0 110.017 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -65.47 -37.28 86.4 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.692 -0.855 . . . . 1.0 108.692 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.5 t -66.35 -46.65 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.797 -1.186 . . . . 1.0 107.797 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.0 tttm -53.66 -40.48 65.92 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.344 -0.389 . . . . 1.0 110.029 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 69.2 mtp85 -65.04 -36.24 83.74 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 109.582 -0.525 . . . . 1.0 109.582 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.6 ttt-85 -68.5 -38.03 80.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.234 -1.025 . . . . 1.0 108.234 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -65.34 -38.19 89.36 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 108.646 -0.872 . . . . 1.0 108.646 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -66.27 -55.4 16.27 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 108.5 -0.926 . . . . 1.0 108.5 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 36.5 mt -57.06 -37.36 71.72 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.756 -0.656 . . . . 1.0 109.859 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.19 97.4 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 122.479 1.133 . . . . 1.0 109.617 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 66.3 ttt-85 -69.29 -39.28 78.43 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 114.871 -1.058 . . . . 1.0 109.329 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.26 -54.7 42.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.493 -0.321 . . . . 1.0 110.173 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 24.4 p -65.22 -28.96 69.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.992 0.425 . . . . 1.0 110.525 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.38 163.29 15.46 Favored Glycine 0 N--CA 1.465 0.603 0 N-CA-C 110.766 -0.934 . . . . 1.0 110.766 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -64.33 -39.44 93.89 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.615 -0.344 . . . . 1.0 110.362 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 . . . . . 0 C--O 1.221 -0.408 0 CA-C-O 118.135 -0.936 . . . . 1.0 110.026 179.801 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.46 ' SD ' ' N ' ' A' ' 1' ' ' MET . 2.3 mpt? . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.093 -0.706 . . . . 1.0 109.093 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -77.26 87.01 3.68 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 116.009 -0.541 . . . . 1.0 110.359 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 52.05 -170.76 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 120.969 0.414 . . . . 1.0 111.025 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.4 m -65.53 147.89 52.65 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.831 0.348 . . . . 1.0 110.353 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.1 p -66.39 140.9 58.1 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.284 -0.416 . . . . 1.0 110.35 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 178.66 -21.72 0.04 OUTLIER Glycine 0 N--CA 1.467 0.707 0 N-CA-C 111.291 -0.724 . . . . 1.0 111.291 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 t -64.25 -28.29 69.63 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.496 0.665 . . . . 1.0 109.893 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 10' ' ' ASN . 69.5 m-20 -63.12 113.44 3.14 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.665 -0.698 . . . . 1.0 110.863 -179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -71.88 11.6 0.51 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.996 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 8' ' ' ASP . 71.8 m-20 59.66 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 121.397 0.618 . . . . 1.0 110.842 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ALA . 67.8 p -60.85 144.37 52.89 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.443 0.64 . . . . 1.0 110.357 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.0 tp -79.15 -1.12 34.65 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 116.042 -0.527 . . . . 1.0 110.433 -179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -99.91 113.56 26.19 Favored 'General case' 0 N--CA 1.482 1.171 0 CA-C-O 121.287 0.565 . . . . 1.0 110.787 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -103.08 142.41 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 CA-C-N 115.869 -0.605 . . . . 1.0 110.093 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -61.21 139.35 58.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 122.237 1.017 . . . . 1.0 111.429 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.02 1.51 88.72 Favored Glycine 0 N--CA 1.473 1.129 0 N-CA-C 111.002 -0.839 . . . . 1.0 111.002 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 77.4 tt0 -85.06 135.46 33.99 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-O 121.028 0.442 . . . . 1.0 110.741 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.494 ' NH1' ' CD1' ' A' ' 67' ' ' TYR . 27.4 ttp85 -80.22 127.25 32.13 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.545 0.688 . . . . 1.0 109.236 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.1 m -132.41 174.05 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 122.232 1.015 . . . . 1.0 110.356 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 84.0 mt -120.54 145.65 47.11 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 122.179 0.99 . . . . 1.0 110.338 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 48.4 t -130.59 130.49 44.08 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.511 -0.768 . . . . 1.0 110.027 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -59.47 -52.77 64.14 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.689 1.233 . . . . 1.0 111.31 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 81.4 t60 54.13 14.7 0.76 Allowed 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.42 -0.809 . . . . 1.0 110.445 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 146.03 -170.66 27.16 Favored Glycine 0 CA--C 1.543 1.831 0 CA-C-N 115.554 -0.748 . . . . 1.0 111.617 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -55.14 -2.37 0.23 Allowed 'Trans proline' 0 N--CA 1.51 2.483 0 C-N-CA 122.308 2.005 . . . . 1.0 113.251 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' H ' ' C ' ' A' ' 24' ' ' GLY . 1.4 tp -122.47 -175.45 3.14 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 121.635 0.731 . . . . 1.0 110.505 -178.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.5 mt -125.09 140.89 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-N 115.376 -0.829 . . . . 1.0 109.763 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -130.99 159.57 37.11 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.582 0.706 . . . . 1.0 111.021 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -83.89 131.79 34.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.93 -0.577 . . . . 1.0 111.046 -179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -147.41 173.99 12.11 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 116.11 -0.496 . . . . 1.0 109.789 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -147.62 148.6 31.27 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-O 121.801 0.81 . . . . 1.0 111.049 -179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.5 t -91.87 114.01 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 115.962 -0.563 . . . . 1.0 109.512 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 56.5 tp -89.1 -32.25 17.62 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 122.1 -0.375 . . . . 1.0 110.124 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.9 ttmm -155.09 145.04 21.63 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 121.434 0.635 . . . . 1.0 110.001 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.2 t -131.12 144.55 51.48 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.723 -0.672 . . . . 1.0 110.818 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.673 ' O ' HG21 ' A' ' 42' ' ' VAL . 25.1 ttpp -114.82 88.53 16.87 Favored Pre-proline 0 N--CA 1.488 1.449 0 CA-C-O 118.614 -0.708 . . . . 1.0 110.06 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -84.72 17.43 1.75 Allowed 'Trans proline' 0 N--CA 1.508 2.343 0 C-N-CA 122.096 1.864 . . . . 1.0 112.713 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -77.76 9.46 3.46 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 120.748 0.309 . . . . 1.0 111.149 -179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -158.02 161.43 38.09 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-O 121.793 0.806 . . . . 1.0 111.468 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 58.6 p -144.08 107.74 4.94 Favored Pre-proline 0 CA--C 1.563 1.475 0 CA-C-O 117.922 -1.037 . . . . 1.0 111.357 -179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -68.43 -171.23 5.58 Favored 'Cis proline' 0 N--CA 1.514 2.708 0 CA-C-N 120.803 1.322 . . . . 1.0 111.037 0.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.891 HG22 ' H ' ' A' ' 43' ' ' GLU . 9.4 p -166.59 -169.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 CA-C-N 116.007 -0.542 . . . . 1.0 110.901 179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.891 ' H ' HG22 ' A' ' 42' ' ' VAL . 16.2 pt-20 -116.75 159.65 21.96 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 123.048 1.404 . . . . 1.0 109.739 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -133.5 146.16 50.83 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.663 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -84.6 100.95 11.76 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 115.26 -0.882 . . . . 1.0 109.972 -179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.89 139.46 33.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 CA-C-O 122.527 1.156 . . . . 1.0 109.119 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -142.3 137.37 30.56 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 115.287 -0.87 . . . . 1.0 109.341 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -72.27 129.65 38.93 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.654 0.74 . . . . 1.0 110.142 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.21 146.78 47.09 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.113 -0.494 . . . . 1.0 110.882 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.9 17.12 75.6 Favored Glycine 0 N--CA 1.474 1.172 0 N-CA-C 111.396 -0.682 . . . . 1.0 111.396 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.2 m95 -140.63 174.26 10.69 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.854 0.835 . . . . 1.0 111.053 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.5 t -63.31 142.12 58.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.616 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -82.64 -8.4 59.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.194 0.598 . . . . 1.0 110.932 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -71.29 -2.86 17.65 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.935 -0.478 . . . . 1.0 110.511 -179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.3 t-105 -65.06 -36.48 84.48 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.638 -0.504 . . . . 1.0 109.638 -179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 66.0 t0 32.48 77.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.972 0.909 . . . . 1.0 113.319 178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -112.79 111.9 23.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.525 -0.734 . . . . 1.0 110.85 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -86.06 134.5 33.83 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 108.398 -0.964 . . . . 1.0 108.398 178.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 34.6 m -140.98 148.81 53.68 Favored Pre-proline 0 N--CA 1.501 2.094 0 N-CA-C 112.691 0.626 . . . . 1.0 112.691 -178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.76 154.44 43.75 Favored 'Trans proline' 0 N--CA 1.511 2.51 0 C-N-CA 121.362 1.375 . . . . 1.0 111.631 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -50.43 -20.69 1.19 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.687 0.756 . . . . 1.0 111.66 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -64.08 -41.93 97.14 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.164 -0.471 . . . . 1.0 111.642 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -88.45 -3.27 58.86 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 122.029 -0.419 . . . . 1.0 111.443 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 42.8 t -97.16 131.13 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 CA-C-O 121.953 0.882 . . . . 1.0 109.756 179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.2 tp -120.91 133.89 55.29 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-O 121.839 0.828 . . . . 1.0 109.886 179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.7 ptpt -67.89 158.56 32.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.819 -0.628 . . . . 1.0 110.568 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.494 ' CD1' ' NH1' ' A' ' 18' ' ' ARG . 67.2 t80 -89.18 122.07 32.11 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.955 -0.566 . . . . 1.0 109.565 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -154.58 146.79 23.77 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.871 0.367 . . . . 1.0 110.355 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -46.82 -28.73 1.65 Allowed 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.789 -0.641 . . . . 1.0 111.627 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -74.12 -45.26 50.05 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 110.325 -0.25 . . . . 1.0 110.325 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -63.15 -38.47 91.29 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 109.025 -0.732 . . . . 1.0 109.025 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.2 t -64.69 -44.51 96.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 107.752 -1.203 . . . . 1.0 107.752 178.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -59.05 -41.1 87.07 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-O 121.274 0.559 . . . . 1.0 109.715 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.9 mtp85 -64.86 -40.87 95.82 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 116.249 -0.432 . . . . 1.0 109.898 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -65.77 -39.92 91.51 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 122.451 1.12 . . . . 1.0 108.476 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -66.98 -36.2 81.66 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.456 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -67.94 -52.6 34.24 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 108.547 -0.908 . . . . 1.0 108.547 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.2 mt -60.53 -40.98 93.5 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 115.269 -0.878 . . . . 1.0 109.858 179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -65.15 -34.6 78.78 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 122.01 0.91 . . . . 1.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -73.74 -44.99 54.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.443 -0.799 . . . . 1.0 109.482 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.09 -10.91 60.29 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.101 -0.499 . . . . 1.0 109.693 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 22.6 t -59.0 -31.04 68.43 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.933 0.397 . . . . 1.0 110.885 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -172.67 143.64 7.45 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 110.686 -0.966 . . . . 1.0 110.686 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -63.3 141.77 58.64 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 122.66 -0.317 . . . . 1.0 110.657 -179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 118.022 -0.99 . . . . 1.0 111.297 179.925 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 108.619 -0.882 . . . . 1.0 108.619 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -64.89 160.72 19.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.05 0.452 . . . . 1.0 110.227 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -153.14 156.05 37.9 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.764 0.792 . . . . 1.0 110.149 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 94.1 p -82.16 -115.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.949 -0.569 . . . . 1.0 110.318 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 43.8 p 48.53 91.98 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.552 0.215 . . . . 1.0 111.205 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.17 -48.31 1.4 Allowed Glycine 0 CA--C 1.529 0.925 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -64.9 131.22 46.11 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 117.123 0.461 . . . . 1.0 110.676 -179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 53.25 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.173 0.511 . . . . 1.0 111.349 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 57.52 114.78 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 116.289 -0.414 . . . . 1.0 111.191 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -62.1 -39.48 92.64 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.314 0.578 . . . . 1.0 110.62 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.3 p -63.47 156.59 25.78 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.389 0.614 . . . . 1.0 110.352 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 12' ' ' LEU . 9.8 mp -85.58 -2.9 58.64 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 115.953 -0.567 . . . . 1.0 110.254 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.7 136.45 53.05 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.421 0.629 . . . . 1.0 110.368 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.53 153.57 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 CA-C-N 115.74 -0.663 . . . . 1.0 110.61 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -63.36 146.76 52.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.991 0.9 . . . . 1.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 88.64 -14.47 59.83 Favored Glycine 0 N--CA 1.468 0.774 0 N-CA-C 110.834 -0.906 . . . . 1.0 110.834 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -77.97 143.77 37.31 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 121.466 0.651 . . . . 1.0 110.594 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.441 HH21 ' CD ' ' A' ' 29' ' ' GLU . 56.4 ttt85 -86.67 133.1 33.72 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.829 -0.804 . . . . 1.0 108.829 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.1 m -138.3 167.12 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 122.19 0.995 . . . . 1.0 110.065 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.6 mt -114.62 146.57 40.67 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 122.218 1.009 . . . . 1.0 110.055 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -123.93 125.49 44.7 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-N 115.376 -0.829 . . . . 1.0 110.064 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.411 ' O ' ' O ' ' A' ' 26' ' ' LEU . 77.8 m-85 -55.35 -60.18 3.76 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 122.271 1.034 . . . . 1.0 111.104 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.3 t60 44.08 65.66 0.99 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.589 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.53 -174.32 21.81 Favored Glycine 0 CA--C 1.549 2.156 0 N-CA-C 111.308 -0.717 . . . . 1.0 111.308 -179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -67.6 14.03 0.16 Allowed 'Trans proline' 0 N--CA 1.519 3.023 0 C-N-CA 121.357 1.371 . . . . 1.0 113.463 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' O ' ' O ' ' A' ' 22' ' ' PHE . 14.6 mt -128.41 -175.56 3.55 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.943 0.877 . . . . 1.0 111.084 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.1 mt -125.97 132.3 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 CA-C-N 115.101 -0.954 . . . . 1.0 109.488 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.41 ' CD1' ' N ' ' A' ' 28' ' ' TYR . 52.0 m-85 -124.42 158.06 33.68 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-O 121.712 0.768 . . . . 1.0 110.804 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.441 ' CD ' HH21 ' A' ' 18' ' ' ARG . 98.1 mt-10 -84.11 136.94 33.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 121.96 0.886 . . . . 1.0 111.076 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.49 172.57 14.76 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.873 0.844 . . . . 1.0 109.271 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -140.39 154.37 46.68 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.488 -0.757 . . . . 1.0 110.757 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.4 t -95.75 107.8 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 N-CA-C 109.239 -0.652 . . . . 1.0 109.239 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.4 -42.25 23.12 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.197 0.523 . . . . 1.0 110.244 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 23.5 ttpp -149.32 157.31 43.23 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-O 121.552 0.691 . . . . 1.0 110.357 -178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.2 t -144.03 147.42 33.83 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 115.598 -0.728 . . . . 1.0 110.667 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.476 ' O ' HG21 ' A' ' 42' ' ' VAL . 62.5 tttp -113.41 82.76 6.19 Favored Pre-proline 0 N--CA 1.492 1.653 0 CA-C-O 118.524 -0.75 . . . . 1.0 110.053 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -81.22 9.87 3.66 Favored 'Trans proline' 0 N--CA 1.509 2.412 0 C-N-CA 122.1 1.867 . . . . 1.0 112.734 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.73 2.7 3.07 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 122.47 0.308 . . . . 1.0 111.014 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -160.64 159.19 30.08 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.951 0.882 . . . . 1.0 111.389 -179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 68.9 p -142.84 116.07 6.18 Favored Pre-proline 0 CA--C 1.567 1.611 0 CA-C-O 117.839 -1.077 . . . . 1.0 111.341 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.35 179.06 26.82 Favored 'Cis proline' 0 N--CA 1.508 2.341 0 CA-C-N 120.985 1.387 . . . . 1.0 110.799 0.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.9 p -167.17 175.47 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-N 115.809 -0.632 . . . . 1.0 110.768 -179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' H ' HG22 ' A' ' 42' ' ' VAL . 10.9 pt-20 -95.78 162.0 13.78 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 123.346 1.546 . . . . 1.0 109.607 179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -135.55 146.83 48.42 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.801 -1.09 . . . . 1.0 110.412 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -86.97 101.5 13.49 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 115.009 -0.996 . . . . 1.0 110.459 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 38.3 mm -112.48 141.02 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-O 121.941 0.877 . . . . 1.0 110.286 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -143.76 144.11 31.67 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.801 -0.636 . . . . 1.0 109.749 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -73.37 131.77 42.26 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.678 0.751 . . . . 1.0 110.013 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.84 142.7 57.24 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.158 0.504 . . . . 1.0 110.733 -179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.21 22.47 62.96 Favored Glycine 0 N--CA 1.469 0.89 0 N-CA-C 111.269 -0.733 . . . . 1.0 111.269 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -144.43 165.26 28.44 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.057 0.932 . . . . 1.0 110.865 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 90.7 p -68.08 151.83 46.44 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.553 -0.748 . . . . 1.0 110.365 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.1 -2.42 55.37 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.64 0.776 . . . . 1.0 111.308 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -65.58 -16.68 63.94 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 122.049 -0.407 . . . . 1.0 110.621 -178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 27.0 m95 -65.48 -34.04 77.35 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.476 -0.564 . . . . 1.0 109.476 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 48.0 t0 37.15 73.71 0.09 Allowed 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.919 0.888 . . . . 1.0 112.869 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.57 97.83 10.4 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 121.491 -0.755 . . . . 1.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -84.61 127.99 34.36 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.299 -1.0 . . . . 1.0 108.299 178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -145.98 152.85 48.71 Favored Pre-proline 0 N--CA 1.487 1.419 0 O-C-N 121.877 -0.515 . . . . 1.0 112.058 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -72.86 158.96 49.26 Favored 'Trans proline' 0 N--CA 1.516 2.801 0 C-N-CA 121.42 1.413 . . . . 1.0 112.09 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -52.22 -20.02 2.37 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 121.365 0.602 . . . . 1.0 111.282 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -63.31 -41.57 98.95 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 122.124 -0.36 . . . . 1.0 111.69 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 tpt180 -85.29 -1.8 57.36 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 122.124 -0.36 . . . . 1.0 110.992 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.1 t -96.37 130.31 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 CA-C-O 122.23 1.014 . . . . 1.0 109.595 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.0 tp -121.24 131.36 54.18 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.853 0.835 . . . . 1.0 109.965 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.32 162.06 26.04 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.855 -0.611 . . . . 1.0 110.6 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -90.05 119.53 30.48 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 122.206 1.003 . . . . 1.0 109.417 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.71 ' N ' HD21 ' A' ' 71' ' ' ASN . 44.6 t-20 -154.45 133.17 12.17 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.545 -0.752 . . . . 1.0 110.263 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -45.75 -16.3 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 115.976 -0.556 . . . . 1.0 112.041 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -77.69 -51.25 10.9 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 122.257 -0.277 . . . . 1.0 110.704 179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.71 HD21 ' N ' ' A' ' 68' ' ' ASN . 20.7 p30 -68.54 -30.83 69.7 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 109.005 -0.739 . . . . 1.0 109.005 179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 95.9 t -63.23 -43.22 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 107.383 -1.34 . . . . 1.0 107.383 178.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -61.23 -38.99 88.59 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 123.153 0.581 . . . . 1.0 109.646 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 80.5 mtp180 -64.23 -36.86 85.47 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.194 -0.669 . . . . 1.0 109.194 179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.1 ttt180 -65.14 -40.78 94.88 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -67.78 -35.96 79.62 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.131 -1.063 . . . . 1.0 108.131 178.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -66.5 -52.07 49.96 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 108.642 -0.873 . . . . 1.0 108.642 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.5 mt -60.68 -41.76 95.75 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.161 -0.927 . . . . 1.0 109.96 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.99 -39.09 93.33 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.688 0.756 . . . . 1.0 109.448 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 -73.67 -41.53 62.55 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.574 0.702 . . . . 1.0 109.827 179.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -63.74 -40.54 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.765 -0.652 . . . . 1.0 109.782 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 42.4 t -63.98 -22.64 67.01 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 122.972 0.509 . . . . 1.0 110.34 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.16 -178.51 51.33 Favored Glycine 0 N--CA 1.465 0.61 0 N-CA-C 110.892 -0.883 . . . . 1.0 110.892 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -62.25 167.68 3.94 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.652 -0.322 . . . . 1.0 110.87 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 59.5 ttm-85 . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 118.16 -0.924 . . . . 1.0 109.101 179.853 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtp . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 108.679 -0.86 . . . . 1.0 108.679 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.2 p-10 -169.82 29.78 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 116.35 -0.386 . . . . 1.0 110.705 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -159.81 163.81 34.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.594 0.712 . . . . 1.0 110.536 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 99.8 p -161.23 162.82 31.3 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.182 -0.463 . . . . 1.0 110.353 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m -62.07 -44.3 96.97 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.6 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.31 62.26 5.56 Favored Glycine 0 CA--C 1.523 0.562 0 N-CA-C 111.182 -0.767 . . . . 1.0 111.182 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -59.97 87.23 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.975 0.417 . . . . 1.0 110.011 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -61.91 149.45 40.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.348 0.594 . . . . 1.0 111.164 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 53.71 102.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 116.057 -0.52 . . . . 1.0 111.302 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -62.14 -33.35 74.33 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 121.353 0.597 . . . . 1.0 110.366 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 80.5 p -62.31 158.74 16.64 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.449 0.642 . . . . 1.0 110.317 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.401 ' N ' HD12 ' A' ' 12' ' ' LEU . 9.9 mp -83.61 -8.37 59.32 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 116.089 -0.505 . . . . 1.0 109.958 -179.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -109.01 139.39 43.95 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-O 121.605 0.717 . . . . 1.0 110.537 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.8 t -125.81 143.88 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 CA-C-N 115.58 -0.736 . . . . 1.0 110.251 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -57.56 138.93 54.68 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 121.879 0.847 . . . . 1.0 111.761 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.27 -6.45 83.42 Favored Glycine 0 N--CA 1.477 1.37 0 N-CA-C 111.028 -0.829 . . . . 1.0 111.028 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -78.45 135.59 37.42 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.128 0.489 . . . . 1.0 110.929 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -84.12 127.48 33.94 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.262 -0.644 . . . . 1.0 109.262 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.6 m -134.1 177.27 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 CA-C-O 121.967 0.889 . . . . 1.0 110.569 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.7 mt -116.08 144.33 44.27 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 122.025 0.916 . . . . 1.0 110.234 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -126.05 112.77 16.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 115.745 -0.661 . . . . 1.0 110.656 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -93.24 148.97 21.57 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.446 0.641 . . . . 1.0 110.526 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -115.66 -31.83 5.71 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.008 0.523 . . . . 1.0 109.982 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 153.75 -68.47 0.3 Allowed Glycine 0 CA--C 1.543 1.833 0 N-CA-C 110.408 -1.077 . . . . 1.0 110.408 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -62.12 -40.72 40.19 Favored 'Trans proline' 0 N--CA 1.513 2.647 0 C-N-CA 121.606 1.537 . . . . 1.0 113.444 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.9 tp -155.56 163.13 40.38 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.186 0.517 . . . . 1.0 110.921 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.91 133.66 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.782 -0.644 . . . . 1.0 109.294 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 91.9 m-85 -115.38 157.09 24.38 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.535 0.683 . . . . 1.0 110.564 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.6 tt0 -88.59 140.31 29.58 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.639 0.733 . . . . 1.0 110.851 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -153.58 174.55 14.3 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.738 -0.664 . . . . 1.0 109.53 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -140.16 155.53 46.92 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 122.295 1.045 . . . . 1.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 26.4 t -95.36 107.28 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-N 115.548 -0.751 . . . . 1.0 109.587 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 33' ' ' LEU . 1.1 tt -75.48 -41.43 55.47 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -160.23 159.41 31.46 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 120.89 0.376 . . . . 1.0 110.065 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -138.78 153.72 48.45 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 121.113 0.482 . . . . 1.0 110.952 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.1 tttt -111.61 84.03 4.86 Favored Pre-proline 0 N--CA 1.496 1.869 0 CA-C-O 118.276 -0.869 . . . . 1.0 110.26 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -82.38 11.82 3.06 Favored 'Trans proline' 0 N--CA 1.509 2.429 0 C-N-CA 121.854 1.703 . . . . 1.0 112.304 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -68.97 0.62 4.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.714 0.292 . . . . 1.0 111.012 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -162.49 160.77 26.57 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.585 0.707 . . . . 1.0 111.387 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.7 p -142.5 117.69 6.67 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.876 -1.059 . . . . 1.0 111.264 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.3 -179.81 21.26 Favored 'Cis proline' 0 N--CA 1.511 2.547 0 CA-C-N 120.988 1.388 . . . . 1.0 110.49 -0.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.625 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.8 p -167.93 176.04 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 115.778 -0.646 . . . . 1.0 110.746 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.625 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.3 pt-20 -96.96 162.65 13.3 Favored 'General case' 0 CA--C 1.545 0.751 0 CA-C-O 123.127 1.441 . . . . 1.0 109.987 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -134.35 154.8 51.14 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 114.967 -1.015 . . . . 1.0 110.634 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -100.5 105.97 17.46 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 114.945 -1.025 . . . . 1.0 110.602 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mm -113.12 142.82 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 114.905 -1.043 . . . . 1.0 110.246 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -144.26 138.46 27.99 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 115.848 -0.615 . . . . 1.0 109.688 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -70.46 133.21 46.62 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.403 0.62 . . . . 1.0 109.994 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.46 135.75 53.59 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.426 -0.352 . . . . 1.0 110.893 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.1 19.87 61.97 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 111.392 -0.683 . . . . 1.0 111.392 179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 97.3 m95 -139.49 164.55 29.59 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-O 122.146 0.974 . . . . 1.0 110.954 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 88.7 p -62.8 132.08 50.99 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.508 -0.769 . . . . 1.0 110.7 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -82.12 -5.99 58.84 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.439 0.695 . . . . 1.0 111.037 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -69.46 -11.35 60.75 Favored 'General case' 0 N--CA 1.467 0.387 0 O-C-N 121.949 -0.47 . . . . 1.0 110.467 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -67.64 -26.72 66.37 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 109.795 -0.446 . . . . 1.0 109.795 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 42.14 76.04 0.08 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.007 0.743 . . . . 1.0 113.007 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.0 tt0 -88.33 88.42 7.62 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 121.489 -0.757 . . . . 1.0 110.631 -179.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -76.43 122.65 24.82 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.846 -0.798 . . . . 1.0 108.846 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -143.69 151.2 52.94 Favored Pre-proline 0 N--CA 1.501 2.121 0 N-CA-C 112.428 0.529 . . . . 1.0 112.428 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -74.48 160.02 42.24 Favored 'Trans proline' 0 N--CA 1.512 2.596 0 C-N-CA 121.47 1.447 . . . . 1.0 112.005 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -54.22 -18.93 4.38 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.949 -0.569 . . . . 1.0 111.545 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -62.26 -41.68 98.67 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 122.149 -0.344 . . . . 1.0 111.672 -179.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 34.4 ttm180 -85.38 -2.72 58.4 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 117.996 0.362 . . . . 1.0 111.027 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 t -111.82 138.07 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-O 121.902 0.858 . . . . 1.0 109.938 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -134.12 156.39 48.38 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.409 0.623 . . . . 1.0 110.629 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.08 148.75 47.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.203 0.525 . . . . 1.0 110.772 -179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -84.82 118.76 24.67 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.845 0.831 . . . . 1.0 109.353 179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 44.4 p30 -155.46 150.12 26.29 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.807 -0.633 . . . . 1.0 110.25 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 55.0 m-20 -47.88 -20.74 0.33 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.807 -0.633 . . . . 1.0 111.937 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -75.17 -50.32 16.65 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.818 0.342 . . . . 1.0 110.641 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -65.95 -31.22 72.01 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.2 -0.667 . . . . 1.0 109.2 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.9 t -67.13 -43.07 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.325 -1.361 . . . . 1.0 107.325 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -58.83 -39.27 80.73 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 109.559 -0.534 . . . . 1.0 109.559 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -63.07 -39.2 94.01 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 109.346 -0.613 . . . . 1.0 109.346 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 -64.87 -41.63 95.5 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -66.69 -36.51 82.68 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.631 -0.877 . . . . 1.0 108.631 178.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.9 tp10 -66.42 -49.63 66.11 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.574 -0.898 . . . . 1.0 108.574 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.1 mt -63.12 -37.7 88.27 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.636 -0.711 . . . . 1.0 109.533 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -59.68 -38.88 82.74 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 116.121 -0.49 . . . . 1.0 109.986 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 35.5 mmm-85 -65.92 -42.05 90.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 109.204 -0.665 . . . . 1.0 109.204 178.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.01 -41.09 95.67 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 109.741 -0.466 . . . . 1.0 109.741 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 43.7 t -61.97 -38.0 86.87 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 122.72 0.408 . . . . 1.0 110.779 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' ARG . . . -62.88 -40.31 99.1 Favored Glycine 0 CA--C 1.524 0.594 0 N-CA-C 110.963 -0.855 . . . . 1.0 110.963 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 56.89 -79.62 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.699 0.4 . . . . 1.0 111.206 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' GLY . 58.1 ttp180 . . . . . 0 CA--C 1.538 0.496 0 CA-C-O 118.005 -0.997 . . . . 1.0 110.497 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtm . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 108.901 -0.777 . . . . 1.0 108.901 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -65.76 164.75 14.02 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.159 -0.473 . . . . 1.0 110.221 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -61.72 -44.81 96.2 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 120.979 0.419 . . . . 1.0 110.233 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.7 m 53.18 -167.78 0.06 Allowed 'General case' 0 N--CA 1.469 0.504 0 O-C-N 122.24 -0.287 . . . . 1.0 111.073 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.2 m -61.84 -45.43 93.83 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.928 0.394 . . . . 1.0 110.808 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -175.53 -167.62 34.83 Favored Glycine 0 N--CA 1.464 0.547 0 N-CA-C 111.21 -0.756 . . . . 1.0 111.21 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -63.66 151.55 41.49 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 122.5 -0.412 . . . . 1.0 110.67 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 21.8 p-10 -166.44 80.2 0.25 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.487 0.66 . . . . 1.0 110.775 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.16 147.73 50.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.928 -0.578 . . . . 1.0 110.772 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -64.01 -39.82 94.95 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.087 -0.338 . . . . 1.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 81.9 p -65.52 154.44 38.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.342 0.591 . . . . 1.0 110.298 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 44.0 mt -83.16 -8.96 59.42 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.06 -0.518 . . . . 1.0 110.417 -179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -101.81 131.74 47.96 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 121.322 0.582 . . . . 1.0 110.745 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 44.1 t -124.42 141.25 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 CA-C-N 115.84 -0.618 . . . . 1.0 110.209 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -60.74 141.17 57.18 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 122.079 0.942 . . . . 1.0 111.45 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 89.45 -6.33 83.33 Favored Glycine 0 N--CA 1.472 1.072 0 N-CA-C 110.962 -0.855 . . . . 1.0 110.962 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 79.0 tt0 -88.33 146.76 25.12 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-O 121.487 0.66 . . . . 1.0 111.232 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.0 mpt_? -69.5 148.44 49.5 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.676 -0.861 . . . . 1.0 108.676 179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 4.5 p -156.32 149.85 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-O 121.785 0.803 . . . . 1.0 109.788 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.3 mt -105.5 134.94 47.79 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.786 0.803 . . . . 1.0 109.972 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 47.0 t -122.17 112.9 18.76 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.969 -0.56 . . . . 1.0 110.319 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -98.43 153.38 18.63 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.924 0.868 . . . . 1.0 109.753 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.427 ' CE1' ' CE1' ' A' ' 28' ' ' TYR . 21.7 p80 -164.9 22.06 0.05 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.906 -0.496 . . . . 1.0 110.118 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -179.21 -152.94 11.03 Favored Glycine 0 CA--C 1.547 2.04 0 CA-C-O 119.062 -0.854 . . . . 1.0 111.724 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -78.82 2.89 7.82 Favored 'Trans proline' 0 N--CA 1.511 2.526 0 CA-C-N 119.393 1.596 . . . . 1.0 112.622 -179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.8 mt -136.03 152.97 51.46 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.348 1.07 . . . . 1.0 111.11 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 77.1 mt -100.71 129.04 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 114.659 -1.155 . . . . 1.0 109.428 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.427 ' CE1' ' CE1' ' A' ' 23' ' ' HIS . 83.8 m-85 -108.74 153.1 23.94 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.382 0.61 . . . . 1.0 110.772 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 79.1 tt0 -84.67 144.84 28.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.188 -0.46 . . . . 1.0 110.98 -179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.05 176.92 11.65 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 121.676 0.75 . . . . 1.0 109.776 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -148.61 142.44 25.7 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.512 1.148 . . . . 1.0 110.332 -179.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.0 t -85.71 122.27 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 CA-C-N 115.348 -0.842 . . . . 1.0 109.977 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 47.1 tp -96.72 -31.63 12.57 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.894 -0.409 . . . . 1.0 109.894 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -153.18 145.8 24.23 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.417 0.627 . . . . 1.0 109.976 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.3 t -133.92 147.17 51.06 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.71 -0.677 . . . . 1.0 110.795 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.3 tttt -112.14 88.19 10.03 Favored Pre-proline 0 N--CA 1.496 1.84 0 CA-C-O 118.223 -0.894 . . . . 1.0 110.052 178.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -84.72 13.26 2.81 Favored 'Trans proline' 0 N--CA 1.512 2.599 0 C-N-CA 121.925 1.75 . . . . 1.0 112.473 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.54 10.75 2.92 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 122.548 0.339 . . . . 1.0 111.158 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -163.32 156.91 19.5 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.513 0.673 . . . . 1.0 111.171 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 72.2 p -143.38 112.67 5.56 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.103 -0.951 . . . . 1.0 111.318 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -70.72 -178.46 18.28 Favored 'Cis proline' 0 N--CA 1.514 2.678 0 CA-C-N 120.729 1.296 . . . . 1.0 110.709 0.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.586 HG22 ' H ' ' A' ' 43' ' ' GLU . 13.8 p -167.44 175.06 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.892 -0.595 . . . . 1.0 110.899 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.586 ' H ' HG22 ' A' ' 42' ' ' VAL . 15.4 pt-20 -97.39 162.04 13.51 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-O 123.051 1.405 . . . . 1.0 110.201 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -135.0 148.52 49.98 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 122.345 1.069 . . . . 1.0 110.572 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -86.08 100.77 12.41 Favored 'General case' 0 N--CA 1.484 1.269 0 CA-C-N 114.702 -1.135 . . . . 1.0 110.19 -179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -106.19 140.29 24.75 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 CA-C-N 115.049 -0.978 . . . . 1.0 109.42 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.7 p-80 -142.88 144.08 32.31 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.612 -0.514 . . . . 1.0 109.612 178.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -79.08 133.02 36.79 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.305 0.574 . . . . 1.0 109.891 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.37 133.24 52.21 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 120.944 0.402 . . . . 1.0 110.964 -179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 83.11 24.19 52.86 Favored Glycine 0 N--CA 1.473 1.152 0 N-CA-C 111.365 -0.694 . . . . 1.0 111.365 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -142.78 162.81 34.49 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 122.18 0.991 . . . . 1.0 110.939 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -65.53 140.96 58.61 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.486 -0.779 . . . . 1.0 110.65 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 24.6 pttm -85.16 -6.14 59.3 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.433 0.693 . . . . 1.0 111.241 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -65.63 -11.24 42.92 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 121.943 -0.473 . . . . 1.0 110.709 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 30.5 m95 -70.7 -27.04 63.7 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 109.586 -0.524 . . . . 1.0 109.586 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 40.02 73.45 0.12 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.813 0.845 . . . . 1.0 112.632 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 70.0 tt0 -84.68 85.48 7.43 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.483 -0.76 . . . . 1.0 110.33 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -81.6 123.56 28.78 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.455 -0.943 . . . . 1.0 108.455 179.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.8 m -142.76 158.6 59.34 Favored Pre-proline 0 N--CA 1.501 2.113 0 N-CA-C 113.003 0.742 . . . . 1.0 113.003 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -73.18 157.66 50.07 Favored 'Trans proline' 0 N--CA 1.513 2.624 0 C-N-CA 121.821 1.681 . . . . 1.0 111.717 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -52.95 -28.94 25.98 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.041 -0.527 . . . . 1.0 111.573 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -60.37 -42.12 95.15 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.956 0.354 . . . . 1.0 111.956 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -82.21 -0.25 44.32 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-O 120.889 0.376 . . . . 1.0 111.151 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 48.1 t -109.9 140.47 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 CA-C-O 121.815 0.817 . . . . 1.0 110.495 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.8 tp -124.48 134.9 52.9 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.836 0.827 . . . . 1.0 110.414 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -65.21 150.2 48.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.865 -0.607 . . . . 1.0 110.957 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -82.49 118.2 23.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-O 121.449 0.642 . . . . 1.0 109.49 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -153.51 139.79 18.53 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.283 -0.417 . . . . 1.0 110.152 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -46.4 -28.94 1.5 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.627 -0.715 . . . . 1.0 111.58 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -71.39 -45.99 61.43 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 122.368 0.267 . . . . 1.0 110.307 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -65.19 -35.32 80.71 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.658 0.742 . . . . 1.0 109.051 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.5 t -65.45 -43.49 94.55 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 N-CA-C 107.83 -1.174 . . . . 1.0 107.83 178.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.8 tppt? -54.93 -40.88 70.35 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.285 0.564 . . . . 1.0 110.188 179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -64.59 -38.78 92.19 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 109.506 -0.553 . . . . 1.0 109.506 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 69.7 ttt-85 -65.21 -41.19 94.71 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 108.452 -0.944 . . . . 1.0 108.452 178.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -66.56 -37.04 84.12 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.515 -0.92 . . . . 1.0 108.515 178.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -65.37 -49.58 68.8 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.714 -0.847 . . . . 1.0 108.714 179.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.1 mt -62.8 -39.38 94.09 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 115.68 -0.691 . . . . 1.0 109.478 178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.46 -43.33 88.85 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.101 0.477 . . . . 1.0 110.12 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -70.39 -37.45 74.5 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 108.925 -0.768 . . . . 1.0 108.925 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -60.35 -53.95 51.47 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.405 -0.361 . . . . 1.0 110.258 -179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 31.2 p -66.83 -23.32 66.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 1.0 110.444 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -61.52 -40.67 99.02 Favored Glycine 0 CA--C 1.522 0.509 0 N-CA-C 111.464 -0.655 . . . . 1.0 111.464 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -63.05 140.52 58.88 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.837 0.351 . . . . 1.0 110.655 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 61.0 ttp180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.395 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 108.411 -0.959 . . . . 1.0 108.411 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -63.99 -35.54 81.05 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 121.003 0.43 . . . . 1.0 110.849 -179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -66.11 141.44 58.12 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.329 0.585 . . . . 1.0 110.343 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -162.97 -69.48 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 116.448 -0.342 . . . . 1.0 110.535 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 70.5 p -67.3 138.35 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 1.0 110.43 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.17 -91.3 0.08 OUTLIER Glycine 0 CA--C 1.524 0.62 0 N-CA-C 111.323 -0.711 . . . . 1.0 111.323 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 35.3 m 54.73 77.95 0.19 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.057 0.456 . . . . 1.0 110.259 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -166.89 167.95 14.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.933 0.873 . . . . 1.0 110.809 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -65.48 83.02 0.06 Allowed 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.499 -0.773 . . . . 1.0 110.65 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -64.91 -21.33 66.8 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.251 0.548 . . . . 1.0 110.262 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 47.6 p -64.62 145.39 56.24 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.046 0.45 . . . . 1.0 110.207 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.2 tp -63.3 -21.29 66.16 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.076 0.465 . . . . 1.0 110.646 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -96.6 129.38 44.0 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.354 0.597 . . . . 1.0 111.076 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 42.0 t -117.76 144.62 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-N 115.839 -0.618 . . . . 1.0 110.381 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.412 ' OD1' ' N ' ' A' ' 16' ' ' GLY . 68.4 t0 -60.21 138.4 57.93 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 122.065 0.935 . . . . 1.0 111.388 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.412 ' N ' ' OD1' ' A' ' 15' ' ' ASP . . . 86.81 0.77 85.67 Favored Glycine 0 N--CA 1.472 1.071 0 N-CA-C 110.918 -0.873 . . . . 1.0 110.918 179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -84.71 133.25 34.38 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-O 121.088 0.471 . . . . 1.0 110.653 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 42.9 ttm180 -79.45 127.21 31.84 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.287 -0.634 . . . . 1.0 109.287 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.1 m -134.16 172.07 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.988 0.899 . . . . 1.0 110.575 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.5 mt -112.62 139.77 47.94 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-O 121.783 0.801 . . . . 1.0 110.301 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 44.2 t -120.27 111.09 17.35 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 115.894 -0.594 . . . . 1.0 110.378 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -99.62 176.82 5.34 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 121.562 0.696 . . . . 1.0 110.129 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -147.45 -32.57 0.29 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.951 -0.468 . . . . 1.0 110.262 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 155.68 -67.74 0.3 Allowed Glycine 0 CA--C 1.537 1.462 0 N-CA-C 110.464 -1.054 . . . . 1.0 110.464 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.72 -50.77 5.94 Favored 'Trans proline' 0 N--CA 1.511 2.548 0 C-N-CA 121.441 1.427 . . . . 1.0 113.295 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.4 tp -148.09 166.27 28.31 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.659 0.742 . . . . 1.0 110.96 -179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 78.8 mt -92.38 144.32 9.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 CA-C-N 115.404 -0.816 . . . . 1.0 109.362 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -128.41 155.47 44.68 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.508 0.67 . . . . 1.0 110.752 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -85.35 136.09 33.62 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.424 0.631 . . . . 1.0 110.875 -179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.17 173.46 13.41 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.88 -0.6 . . . . 1.0 109.765 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -142.7 155.1 44.85 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-O 121.734 0.778 . . . . 1.0 110.964 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -93.42 104.83 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 CA-C-O 121.662 0.744 . . . . 1.0 109.055 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -78.23 -43.27 28.77 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.244 -0.434 . . . . 1.0 110.316 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 18.5 ttmm -152.17 151.76 31.42 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.698 0.761 . . . . 1.0 109.94 -178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 3.1 t -134.56 145.76 49.0 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.476 -0.784 . . . . 1.0 110.875 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 42' ' ' VAL . 36.2 ttpt -111.22 90.28 11.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-O 118.41 -0.805 . . . . 1.0 109.877 179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -86.66 11.17 3.36 Favored 'Trans proline' 0 N--CA 1.509 2.395 0 C-N-CA 122.07 1.846 . . . . 1.0 112.336 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -71.85 10.74 0.64 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.493 0.317 . . . . 1.0 111.076 -179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -161.21 160.25 29.8 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-O 121.868 0.842 . . . . 1.0 111.315 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 73.9 p -144.0 108.01 4.98 Favored Pre-proline 0 CA--C 1.565 1.538 0 CA-C-O 117.971 -1.014 . . . . 1.0 111.468 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -69.8 -173.82 8.91 Favored 'Cis proline' 0 N--CA 1.515 2.778 0 CA-C-N 120.949 1.375 . . . . 1.0 110.804 0.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.825 HG22 ' H ' ' A' ' 43' ' ' GLU . 7.3 p -166.29 -174.39 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 CA-C-N 116.074 -0.512 . . . . 1.0 111.092 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.825 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -110.76 160.76 16.43 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-O 123.833 1.778 . . . . 1.0 109.617 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -134.61 147.74 50.27 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 114.216 -1.356 . . . . 1.0 110.601 -178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -96.46 110.23 22.64 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.456 0.646 . . . . 1.0 110.022 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 37.4 mm -112.01 147.84 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 CA-C-O 122.508 1.147 . . . . 1.0 109.956 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -143.05 145.15 32.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.384 -0.826 . . . . 1.0 109.609 178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -75.64 136.87 40.44 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 121.344 0.592 . . . . 1.0 110.094 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.04 126.19 28.71 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.129 -0.357 . . . . 1.0 110.913 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 87.91 25.98 30.48 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.513 -0.635 . . . . 1.0 111.513 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -138.62 163.83 31.05 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.243 1.02 . . . . 1.0 110.893 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.9 m -68.77 153.12 44.36 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 115.505 -0.771 . . . . 1.0 110.462 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -86.57 -5.94 59.01 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.947 0.899 . . . . 1.0 111.495 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -68.57 -13.22 62.19 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.941 -0.474 . . . . 1.0 110.682 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -67.0 -31.29 71.75 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.637 -0.505 . . . . 1.0 109.637 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 41.72 73.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.503 0.721 . . . . 1.0 112.767 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -94.4 91.55 6.72 Favored 'General case' 0 N--CA 1.476 0.871 0 O-C-N 121.422 -0.799 . . . . 1.0 110.464 -179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.9 m95 -93.77 125.04 38.16 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 108.414 -0.958 . . . . 1.0 108.414 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.3 m -146.7 151.22 42.03 Favored Pre-proline 0 N--CA 1.501 2.115 0 CA-C-O 118.706 -0.664 . . . . 1.0 112.708 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -60.19 159.03 27.91 Favored 'Trans proline' 0 N--CA 1.515 2.764 0 C-N-CA 120.7 0.933 . . . . 1.0 112.644 178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -53.14 -21.6 5.18 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 115.75 -0.659 . . . . 1.0 111.403 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -62.32 -41.8 98.84 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.184 -0.322 . . . . 1.0 111.6 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -79.31 -2.47 41.57 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 122.19 -0.319 . . . . 1.0 110.938 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.8 t -103.49 130.36 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 CA-C-O 121.936 0.874 . . . . 1.0 110.369 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.8 tp -114.6 134.55 54.96 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.72 0.772 . . . . 1.0 110.224 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.95 154.4 42.0 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.948 -0.569 . . . . 1.0 110.806 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -85.71 121.59 28.6 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 121.527 0.68 . . . . 1.0 109.393 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -154.3 140.68 18.69 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.165 -0.471 . . . . 1.0 110.399 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -44.55 -30.27 0.86 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 115.872 -0.604 . . . . 1.0 111.47 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -70.73 -47.01 61.92 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.48 0.312 . . . . 1.0 110.388 179.2 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -63.88 -36.45 83.98 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.969 -0.752 . . . . 1.0 108.969 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 92.9 t -65.5 -45.5 92.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 107.661 -1.237 . . . . 1.0 107.661 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -58.65 -40.0 82.16 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.732 -0.47 . . . . 1.0 109.732 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 86.7 mtt-85 -63.43 -38.97 93.2 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.614 -0.513 . . . . 1.0 109.614 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -64.68 -41.36 96.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 178.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -66.34 -38.11 86.9 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 108.389 -0.967 . . . . 1.0 108.389 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -65.55 -53.4 42.58 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 121.814 0.816 . . . . 1.0 108.957 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 22.1 mt -58.74 -38.9 79.4 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 115.296 -0.866 . . . . 1.0 109.756 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -66.51 -34.1 77.16 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.289 0.566 . . . . 1.0 109.596 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 1.7 tpm_? -63.07 -44.58 95.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.49 0.662 . . . . 1.0 109.368 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -61.67 -39.41 91.28 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.852 -0.613 . . . . 1.0 110.113 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 71.8 m -63.71 -35.8 81.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 122.54 0.336 . . . . 1.0 110.363 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -65.02 164.1 36.65 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 110.69 -0.964 . . . . 1.0 110.69 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -59.94 134.77 57.35 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.788 0.327 . . . . 1.0 111.003 -179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.471 0.594 0 CA-C-O 117.91 -1.043 . . . . 1.0 111.318 179.714 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 tpp . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.675 -0.861 . . . . 1.0 108.675 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -168.37 117.75 0.74 Allowed 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.772 0.32 . . . . 1.0 110.2 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -61.03 -47.45 86.36 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.294 0.568 . . . . 1.0 110.566 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 95.7 p -167.6 160.92 13.31 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.011 0.434 . . . . 1.0 110.205 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 29.6 m -65.31 132.56 49.34 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 116.228 -0.442 . . . . 1.0 110.519 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 177.84 177.58 46.74 Favored Glycine 0 N--CA 1.466 0.642 0 N-CA-C 111.157 -0.777 . . . . 1.0 111.157 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.4 t -67.35 158.99 30.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.455 0.645 . . . . 1.0 110.427 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -149.29 11.73 0.81 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 115.602 -0.726 . . . . 1.0 110.471 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 11' ' ' THR . . . -69.5 2.1 3.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.696 -0.229 . . . . 1.0 110.792 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 18.2 m120 58.11 -73.68 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 122.77 0.428 . . . . 1.0 110.989 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.499 ' N ' ' O ' ' A' ' 9' ' ' ALA . 80.4 p -59.65 156.92 12.71 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.66 0.743 . . . . 1.0 109.945 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.6 mt -85.94 -0.23 54.92 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.902 -0.59 . . . . 1.0 110.375 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -104.02 134.37 47.4 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-O 121.453 0.644 . . . . 1.0 111.047 -179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.37 151.42 31.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 CA-C-N 115.67 -0.695 . . . . 1.0 110.467 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.15 140.43 55.89 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.995 0.902 . . . . 1.0 111.505 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.61 -4.13 86.45 Favored Glycine 0 N--CA 1.474 1.216 0 N-CA-C 111.156 -0.778 . . . . 1.0 111.156 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -77.86 128.35 33.84 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 120.742 0.306 . . . . 1.0 110.858 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -78.76 127.63 32.32 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.255 -0.646 . . . . 1.0 109.255 179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 33.3 m -139.66 168.99 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 CA-C-O 121.416 0.627 . . . . 1.0 110.632 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.5 mt -109.59 139.49 44.54 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-O 121.505 0.669 . . . . 1.0 110.112 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.0 t -127.02 120.36 28.85 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.138 0.494 . . . . 1.0 110.629 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 54.4 p90 -101.96 163.61 12.15 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-O 121.783 0.802 . . . . 1.0 110.01 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 80.5 t60 -165.51 14.82 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.876 -0.515 . . . . 1.0 110.037 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 26' ' ' LEU . . . 178.8 -167.97 38.63 Favored Glycine 0 CA--C 1.543 1.801 0 N-CA-C 111.457 -0.657 . . . . 1.0 111.457 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.78 -1.34 0.24 Allowed 'Trans proline' 0 N--CA 1.512 2.604 0 C-N-CA 122.125 1.883 . . . . 1.0 113.331 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' H ' ' C ' ' A' ' 24' ' ' GLY . 18.7 mt -131.93 155.48 47.83 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.677 1.227 . . . . 1.0 111.154 -179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 66.8 mt -107.16 130.49 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 CA-C-N 114.423 -1.262 . . . . 1.0 109.084 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.71 153.61 27.43 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.058 0.543 . . . . 1.0 110.745 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -80.67 146.03 31.33 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.511 0.672 . . . . 1.0 110.872 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -154.0 173.48 15.94 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.533 0.682 . . . . 1.0 109.514 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -143.39 153.24 42.49 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-O 122.064 0.935 . . . . 1.0 110.64 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 29.6 t -91.64 118.22 36.57 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 115.702 -0.681 . . . . 1.0 109.9 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 tp -99.39 -33.32 10.75 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 119.145 -0.455 . . . . 1.0 110.181 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -152.88 145.95 24.61 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-O 121.475 0.655 . . . . 1.0 109.762 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.6 p -132.74 145.11 50.75 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.643 -0.708 . . . . 1.0 110.591 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.661 ' O ' HG21 ' A' ' 42' ' ' VAL . 88.8 tttt -116.45 81.22 10.83 Favored Pre-proline 0 N--CA 1.487 1.405 0 CA-C-O 118.504 -0.76 . . . . 1.0 109.603 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -82.76 13.63 2.55 Favored 'Trans proline' 0 N--CA 1.512 2.606 0 C-N-CA 122.641 2.227 . . . . 1.0 112.467 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -71.53 10.43 0.64 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.495 0.318 . . . . 1.0 110.864 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -165.65 161.46 18.27 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.578 0.704 . . . . 1.0 111.391 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 71.5 p -143.21 111.58 5.54 Favored Pre-proline 0 CA--C 1.568 1.641 0 CA-C-O 117.817 -1.087 . . . . 1.0 111.338 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -69.89 -175.99 12.05 Favored 'Cis proline' 0 N--CA 1.515 2.789 0 CA-C-N 120.948 1.374 . . . . 1.0 110.683 0.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG22 ' H ' ' A' ' 43' ' ' GLU . 8.8 p -166.46 -168.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 115.908 -0.587 . . . . 1.0 110.981 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.878 ' H ' HG22 ' A' ' 42' ' ' VAL . 14.8 pt-20 -115.82 157.92 23.68 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 122.941 1.353 . . . . 1.0 110.035 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -131.88 151.26 51.81 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 115.103 -0.953 . . . . 1.0 110.773 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 9.0 t80 -93.64 102.65 14.83 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.014 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.4 mm -110.78 139.01 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 115.406 -0.816 . . . . 1.0 109.76 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -141.4 136.09 31.04 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 109.528 -0.545 . . . . 1.0 109.528 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -75.26 133.64 41.29 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.361 0.601 . . . . 1.0 110.192 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 137.66 52.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.862 0.363 . . . . 1.0 110.93 -179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.14 8.71 81.46 Favored Glycine 0 N--CA 1.472 1.082 0 N-CA-C 111.483 -0.647 . . . . 1.0 111.483 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 93.7 m95 -130.56 166.96 19.49 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.963 0.887 . . . . 1.0 111.048 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 47.0 t -63.6 133.17 53.26 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.65 -0.704 . . . . 1.0 110.705 -179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -84.5 -10.9 57.04 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.971 0.508 . . . . 1.0 111.02 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 -67.97 -10.1 50.79 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 121.935 -0.478 . . . . 1.0 110.425 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 17.0 t-105 -67.82 -26.58 66.13 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 109.78 -0.452 . . . . 1.0 109.78 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 42.72 74.0 0.12 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.668 0.787 . . . . 1.0 112.641 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.7 tp10 -83.08 85.22 7.22 Favored 'General case' 0 N--CA 1.474 0.751 0 O-C-N 121.513 -0.742 . . . . 1.0 110.4 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -80.25 119.51 23.09 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 108.494 -0.928 . . . . 1.0 108.494 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.9 m -145.26 150.62 45.5 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.902 -0.498 . . . . 1.0 112.329 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -73.54 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.51 2.478 0 C-N-CA 121.54 1.493 . . . . 1.0 111.857 178.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -49.68 -27.94 5.34 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 115.532 -0.758 . . . . 1.0 111.761 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -55.43 -35.39 65.36 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 112.061 0.393 . . . . 1.0 112.061 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpp85 -89.69 -5.55 56.94 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 120.934 0.397 . . . . 1.0 111.156 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.3 t -116.12 141.93 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 CA-C-O 121.693 0.759 . . . . 1.0 110.336 -178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -134.22 158.86 42.63 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 122.021 0.915 . . . . 1.0 110.673 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -70.41 141.09 52.18 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.699 -0.682 . . . . 1.0 110.675 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -79.99 126.13 30.64 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.496 0.665 . . . . 1.0 109.417 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -151.63 156.47 40.47 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 116.239 -0.437 . . . . 1.0 110.442 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -63.74 -20.65 65.91 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.878 -0.601 . . . . 1.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -90.82 -27.9 18.55 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.039 0.536 . . . . 1.0 111.131 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -77.37 -47.34 20.12 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.239 0.542 . . . . 1.0 109.58 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -59.45 -27.02 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 N-CA-C 108.154 -1.054 . . . . 1.0 108.154 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -65.53 -36.71 84.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.405 -0.816 . . . . 1.0 108.943 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -59.28 -34.54 72.39 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.147 -0.686 . . . . 1.0 109.147 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 61.1 ttp180 -68.85 -40.29 79.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.357 -0.979 . . . . 1.0 108.357 178.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -64.97 -38.53 91.26 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.479 -0.934 . . . . 1.0 108.479 179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -63.73 -49.73 71.89 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.767 -0.827 . . . . 1.0 108.767 178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 42.8 mt -62.85 -34.12 76.69 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.029 -0.532 . . . . 1.0 109.688 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.55 91.58 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 116.345 -0.389 . . . . 1.0 110.145 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 90.3 mtt-85 -68.23 -44.72 75.07 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 109.274 -0.639 . . . . 1.0 109.274 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -64.6 -40.89 96.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.423 -0.353 . . . . 1.0 110.101 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.1 t -63.47 -42.08 98.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.967 0.413 . . . . 1.0 110.652 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -179.21 -173.7 44.68 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.98 -0.848 . . . . 1.0 110.98 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.423 ' H ' ' H ' ' A' ' 85' ' ' ARG . 11.0 pt-20 -169.08 -0.55 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.731 0 O-C-N 122.669 -0.313 . . . . 1.0 110.807 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.423 ' H ' ' H ' ' A' ' 84' ' ' GLU . 78.1 mtt85 . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 118.083 -0.961 . . . . 1.0 111.191 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 108.573 -0.899 . . . . 1.0 108.573 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 27.7 p30 -64.19 152.83 39.69 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.219 -0.446 . . . . 1.0 110.385 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.43 ' H ' ' H ' ' A' ' 4' ' ' SER . 68.6 t80 -167.95 -13.37 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 110.166 -0.309 . . . . 1.0 110.166 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.43 ' H ' ' H ' ' A' ' 3' ' ' TYR . 98.4 p -60.94 -32.9 72.4 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.789 0.328 . . . . 1.0 110.776 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 59.1 p -62.06 -47.07 86.34 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.362 -0.381 . . . . 1.0 110.726 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.07 83.17 0.05 OUTLIER Glycine 0 N--CA 1.466 0.692 0 N-CA-C 111.314 -0.715 . . . . 1.0 111.314 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -155.76 142.31 18.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.26 0.552 . . . . 1.0 110.691 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -68.45 -68.13 0.42 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.617 0.722 . . . . 1.0 111.114 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.49 139.77 58.8 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.82 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -64.39 -40.34 95.61 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.957 0.408 . . . . 1.0 110.25 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 70.6 p -66.98 159.91 27.56 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.414 0.626 . . . . 1.0 110.133 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 43.2 mt -88.53 -2.62 58.7 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 116.048 -0.524 . . . . 1.0 110.437 -179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -96.43 114.92 26.64 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-O 121.277 0.561 . . . . 1.0 110.458 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 36.0 t -108.37 138.35 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 CA-C-N 115.941 -0.572 . . . . 1.0 109.852 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -61.59 143.27 56.31 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 122.372 1.082 . . . . 1.0 111.463 -179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.13 -3.94 86.54 Favored Glycine 0 N--CA 1.475 1.297 0 N-CA-C 110.974 -0.85 . . . . 1.0 110.974 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -85.77 135.73 33.62 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-O 121.376 0.608 . . . . 1.0 110.832 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -78.93 134.34 36.87 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 109.293 -0.632 . . . . 1.0 109.293 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.7 m -138.64 170.91 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 CA-C-O 121.946 0.879 . . . . 1.0 110.319 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 57.9 mt -113.35 140.35 48.1 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.041 0.924 . . . . 1.0 110.135 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 41.9 t -126.5 123.72 38.42 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 115.686 -0.688 . . . . 1.0 110.573 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 53.2 p90 -110.07 176.72 4.95 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-O 121.85 0.833 . . . . 1.0 110.039 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 70.3 m80 -150.81 -30.29 0.19 Allowed 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.922 -0.486 . . . . 1.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 156.04 -62.58 0.34 Allowed Glycine 0 CA--C 1.539 1.569 0 N-CA-C 110.243 -1.143 . . . . 1.0 110.243 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.58 -54.04 4.8 Favored 'Trans proline' 0 N--CA 1.51 2.493 0 C-N-CA 121.828 1.686 . . . . 1.0 113.56 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tp -157.6 162.49 38.73 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.733 0.777 . . . . 1.0 110.711 -178.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 57.4 mt -84.34 127.32 39.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 115.333 -0.848 . . . . 1.0 109.726 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -112.0 160.52 17.39 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.479 0.657 . . . . 1.0 110.656 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.404 ' CG ' HH12 ' A' ' 75' ' ' ARG . 95.5 mt-10 -88.31 145.15 25.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.976 0.893 . . . . 1.0 110.98 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.87 171.84 17.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.368 -0.833 . . . . 1.0 109.254 179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 tmmm? -141.64 145.33 34.84 Favored 'General case' 0 N--CA 1.481 1.096 0 O-C-N 121.454 -0.779 . . . . 1.0 110.873 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.2 t -88.12 112.29 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 59.0 tp -91.54 -36.54 13.65 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 109.892 -0.41 . . . . 1.0 109.892 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -150.88 143.47 24.39 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.495 0.664 . . . . 1.0 110.094 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 1.8 t -130.02 145.65 51.67 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 115.695 -0.684 . . . . 1.0 110.637 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' O ' HG21 ' A' ' 42' ' ' VAL . 64.1 tttp -113.05 88.84 12.76 Favored Pre-proline 0 N--CA 1.489 1.506 0 CA-C-O 118.448 -0.787 . . . . 1.0 109.908 179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 39' ' ' ALA . 11.6 Cg_endo -86.53 7.95 4.68 Favored 'Trans proline' 0 N--CA 1.504 2.132 0 C-N-CA 122.165 1.91 . . . . 1.0 112.644 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -70.37 11.03 0.38 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.465 0.306 . . . . 1.0 110.965 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 37' ' ' PRO . . . -165.61 157.7 14.86 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.729 0.776 . . . . 1.0 111.389 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 55.0 p -143.42 113.5 5.61 Favored Pre-proline 0 N--CA 1.49 1.553 0 CA-C-O 118.113 -0.946 . . . . 1.0 111.509 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.81 -179.31 20.63 Favored 'Cis proline' 0 N--CA 1.509 2.44 0 CA-C-N 120.766 1.309 . . . . 1.0 110.764 0.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' H ' ' A' ' 43' ' ' GLU . 14.6 p -168.02 173.57 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-N 115.9 -0.591 . . . . 1.0 110.928 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 42' ' ' VAL . 13.8 pt-20 -95.66 167.42 11.3 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 123.205 1.478 . . . . 1.0 109.849 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -139.15 152.11 47.18 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 114.844 -1.071 . . . . 1.0 110.678 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -90.49 102.13 14.87 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-N 115.093 -0.958 . . . . 1.0 110.175 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 36.7 mm -110.82 142.58 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 CA-C-O 121.717 0.77 . . . . 1.0 110.002 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -144.86 142.72 30.15 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 116.131 -0.486 . . . . 1.0 109.801 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -74.19 135.6 42.79 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.454 0.645 . . . . 1.0 109.953 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.74 129.62 40.46 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 116.309 -0.405 . . . . 1.0 111.038 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.28 24.55 43.37 Favored Glycine 0 N--CA 1.474 1.199 0 N-CA-C 111.416 -0.674 . . . . 1.0 111.416 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -139.82 162.13 35.89 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-O 122.208 1.004 . . . . 1.0 110.853 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 53.7 m -63.32 135.62 57.14 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.357 -0.838 . . . . 1.0 110.606 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 22.2 pttp -83.61 -5.79 59.27 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.438 0.695 . . . . 1.0 111.219 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 46.8 p30 -68.95 -13.62 62.55 Favored 'General case' 0 N--CA 1.466 0.37 0 O-C-N 121.936 -0.478 . . . . 1.0 110.442 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 15.6 t-105 -67.98 -28.38 67.39 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.823 -0.436 . . . . 1.0 109.823 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 43.42 73.87 0.13 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.75 0.82 . . . . 1.0 112.648 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -84.94 85.19 7.5 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.398 -0.814 . . . . 1.0 110.256 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -78.37 121.87 25.04 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.221 -1.029 . . . . 1.0 108.221 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -143.3 152.14 56.72 Favored Pre-proline 0 N--CA 1.494 1.773 0 O-C-N 121.82 -0.55 . . . . 1.0 112.108 -179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -71.12 161.57 45.5 Favored 'Trans proline' 0 N--CA 1.511 2.545 0 C-N-CA 121.553 1.502 . . . . 1.0 111.902 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -55.2 -17.08 3.81 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.327 0.584 . . . . 1.0 111.498 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -61.55 -40.14 93.65 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 122.095 -0.378 . . . . 1.0 111.808 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -88.56 -1.43 58.05 Favored 'General case' 0 N--CA 1.48 1.032 0 O-C-N 122.059 -0.401 . . . . 1.0 110.898 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 22.6 t -116.32 138.54 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 CA-C-O 122.416 1.103 . . . . 1.0 109.896 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -138.56 158.75 43.66 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.986 0.898 . . . . 1.0 110.44 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -70.23 153.86 42.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.8 0.81 . . . . 1.0 110.42 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -88.35 116.67 26.74 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.361 -0.836 . . . . 1.0 109.601 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -152.69 150.28 29.28 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 116.236 -0.438 . . . . 1.0 110.468 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -48.08 -25.07 1.28 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 115.8 -0.636 . . . . 1.0 111.595 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -73.81 -47.66 37.01 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 110.264 -0.273 . . . . 1.0 110.264 179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -64.35 -34.15 77.5 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 109.242 -0.651 . . . . 1.0 109.242 179.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.49 -41.23 88.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.507 -1.294 . . . . 1.0 107.507 177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.7 -38.91 79.3 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.642 -0.503 . . . . 1.0 109.642 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 88.9 mtt-85 -62.95 -39.28 94.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 109.65 -0.5 . . . . 1.0 109.65 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 29' ' ' GLU . 41.8 ttm180 -65.91 -42.25 90.39 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.936 -1.135 . . . . 1.0 107.936 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -66.87 -32.14 73.2 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.278 -1.008 . . . . 1.0 108.278 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -71.08 -45.3 64.02 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.315 -0.994 . . . . 1.0 108.315 179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.7 mt -70.82 -28.31 64.52 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.502 -0.772 . . . . 1.0 109.876 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -62.28 -54.19 44.32 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 116.058 -0.519 . . . . 1.0 110.167 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ARG . . . . . . . . . . . . . 15.4 ptp180 -63.75 -27.84 69.47 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.431 0.634 . . . . 1.0 109.352 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.6 tm0? -70.44 -40.96 73.46 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.036 -0.529 . . . . 1.0 109.671 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.86 -43.57 94.6 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 122.9 0.48 . . . . 1.0 110.406 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.35 -152.3 44.63 Favored Glycine 0 CA--C 1.522 0.494 0 N-CA-C 110.94 -0.864 . . . . 1.0 110.94 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 47.0 tp10 53.93 97.82 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 O-C-N 122.702 -0.293 . . . . 1.0 111.065 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 29.3 ptt-85 . . . . . 0 N--CA 1.47 0.574 0 CA-C-O 118.209 -0.901 . . . . 1.0 111.403 -179.863 . . . . . . . . 0 0 . 1 stop_ save_